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Summary 
This master thesis in Public Health Science concentrates on the topic ethnic inequalities in 
cardiovascular health, and consists of two parts. The first part contains a comprehensive 
presentation of relevant theory and a wide discussion of the topic. The second part is the article; 
Ethnic differences in risk factors and total risk of cardiovascular disease in Norway: a cross 
sectional study. The article gives detailed information about methods and results. The aim of this 
study is to examine the relationship between cardiovascular health and ethnic origin. The focus is 
based on previous studies demonstrating ethnic differences in risk of cardiovascular diseases.  
The first part, which is the main thesis, links the topic to the field of public health by presenting 
detailed theory about relevant aspects. Such aspects include cardiovascular diseases and its risk 
factors, equality in health and the concept of ethnicity. Brief summaries of methods and results 
of the article are given in the corresponding sections of the main thesis. Some methodological 
considerations are further discussed before the results from the article are discussed in a wider 
theoretical context, emphasizing the relevance for public health. 
The article describes a cross-sectional study based on data from a main sample of 62 145 
individuals in the age range 40-65 years, who participated in the Cohort of Norway. The aim was 
to examine ethnic differences in risk factors and total risk of cardiovascular diseases, the latter 
calculated based on two different risk equations. Ethnic belonging was indicated by place of 
birth, and participants from 11 different geographical regions were included. Self-reported 
variables, blood samples and physical measurements were used to estimate age-adjusted mean 
levels of CVD risk factors and calculate total risk scores.  
Significant differences were found in risk factors and total risk scores. In particular, participants 
from the Indian subcontinent and Former Yugoslavia showed higher levels of risk factors and 
total risk compared to the other ethnic groups. This was evident in both sexes. The results are 
discussed in the article. 
The discussion in the main thesis presents possible explanations for ethnic differences in 
cardiovascular health. It is concluded that although ethnic differences in genetic susceptibility 
exist, it is likely that underlying causes can be found in the surrounding contexts of individuals. 
More research is needed, in order to identify and address root causes for ethnic inequalities in 
cardiovascular health. 
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Sammendrag 
Denne masteroppgaven i Folkehelsevitenskap fokuserer på temaet etniske ulikheter i 
kardiovaskulær helse, og består av to deler. Den første delen er en kappe som inneholder en 
omfattende presentasjon av relevant teori og en bred diskusjon av emnet. Den andre delen er 
artikkelen; Ethnic differences in risk factors and total risk of cardiovascular disease in Norway: 
a cross sectional study. Artikkelen gir detaljert informasjon om metode og resultater. Studiens 
mål er å undersøke forholdet mellom kardiovaskulær helse og etnisk opprinnelse. Fokuset er 
basert på at tidligere studier har vist at det finnes etniske forskjeller i risiko for hjerte-
karsykdommer.   
I kappen knyttes temaet til folkehelsefeltet gjennom relevant teori om blant annet 
kardiovaskulære sykdommer, risikofaktorer, likhet i helse og etnisitetsbegrepet. Korte 
sammendrag av metode og resultater fra artikkelen gis i de tilsvarende inndelinger i kappen. 
Diskusjon rundt noen metodiske problemstillinger blir presentert, før resultatene fra artikkelen 
og teori blir diskutert i en større sammenheng som vektlegger temaets relevans for folkehelse. 
Artikkelen beskriver en tverrsnittstudie som er basert på et utvalg bestående av 62 145 personer i 
alderen 40-65 år, som deltok i the Cohort of Norway. Målet var å undersøke etniske forskjeller i 
risikofaktorer og total risiko for hjerte-karsykdommer. Total risiko ble regnet ut ved hjelp av to 
forskjellige risiko-score systemer. Deltakernes fødested ble brukt som indikator på etnisk 
tilhørighet, og personer fra 11 ulike føde-regioner ble inkludert. Selvrapporterte variabler, 
blodprøver og fysiske målinger ble brukt for å estimere aldersjusterte gjennomsnittsverdier av 
risikofaktorer for hjerte-karsykdom, og kalkulere total risiko-scorer. 
Signifikante forskjeller ble funnet både i risikofaktorer og i total risiko. Deltakerne fra det 
Indiske subkontinent og tidligere Jugoslavia skilte seg spesielt ut, med relativt høye nivå av både 
risikofaktorer og total risiko. Dette gjaldt både menn og kvinner. Resultatene diskuteres i 
artikkelen. 
Diskusjonen i kappen presenterer mulige årsaksforklaringer for etniske forskjeller i 
kardiovaskulær helse. Det konkluderes med at selv om det er forskjeller i genetisk sårbarhet 
blant ulike etniske grupper, er det sannsynlig at underliggende årsaker har sitt utspring i 
omkringliggende faktorer. Det kreves mer forskning for å kunne identifisere og rette tiltak mot 
slike primære årsaker for etniske ulikheter i kardiovaskulær helse. 
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1.0 Introduction 
1.1 Clearing central concepts 
Health is multidimensional and can be defined in several ways. The World Health Organization 
(WHO) constitution of 1948 defined health as “a state of complete physical, mental and social 
well-being and not merely the absence of disease or infirmity” (WHO 1948).  
Based on this holistic definition of health, public health work is comprehended as the integrative 
and organized efforts of a society to strengthen factors that promote and protect health, prevent 
diseases, and prolong people’s lives (NOU 1998:18; WHO 1998). This comprehensive 
understanding emphasizes that public health is not the responsibility of the health sector alone, 
but should include all sectors involved in a society. It is further underlined that public health 
interventions generally aim at populations rather than the individual (NOU 1998:18). Prevention 
efforts aimed at hindering a first occurrence of disease is called primary prevention (WHO 
1998).   
Just like the health concept, ethnicity is a multidimensional concept, often defined differently by 
different actors. The concept derives from the Greek word “ethnos” which means nation. It 
contains social, cultural and genetic dimensions based on shared belonging, experiences and 
characteristics. Examples of such shared relations might be geographical or social origin, 
collective way of living, communication and beliefs. Consequently, the boundaries of ethnic 
belonging are often fluently and constantly changing (Anand 1999; Barth 1969; Bhopal 2007).  
 
1.2 Cardiovascular diseases:  a public health perspective 
Cardiovascular diseases (CVDs) form a group of diseases highly relevant on the global public 
health agenda; CVD is the leading cause of death and a major cause of disability worldwide 
(WHO 2005). CVDs were previously known as “Western diseases” only affecting industrialized 
countries (WHO 2003) since these countries were first afflicted when industrialization gained 
speed in the 19th and 20th centuries. Changes in living conditions resulted in a transition of the 
most important causes of death and morbidity (Detels & Breslow 2002; Yusuf, S. et al. 2001). 
This shift is called the epidemiologic transition, first termed by Omran in 1971 (Omran 2005), 
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implying that nutritional deficiencies and infectious diseases became less common and were 
replaced by chronic diseases such as cancer, diabetes and CVD (Yassi et al. 2001; Yusuf, S. et 
al. 2001). The epidemiologic transition implied a corresponding transition in risk factors 
associated with diseases (WHO 2009). However, it may be worth to note that the epidemiologic 
transition is not something that belongs to the past. Countries throughout the world are 
constantly in different stages of the transition. In the first stage, representing the earliest stage of 
development, the predominating CVDs are related to infections and nutritional deficiencies. 
Examples of regions in the first stage are Sub-Saharan Africa and rural areas in South Asia 
(Yusuf, S. et al. 2001). In the second stage, the burden of infectious diseases is reduced and 
nutrition improves. CVDs related to hypertension such as stroke caused by bleeding in the brain 
increases. In the following third stage, life expectancy is continuously improving and the 
societies become more affluent. Diets high in fat, cigarette smoking and physical inactivity 
become more common. CVD consequently become predominating and add to the burden of 
communicable diseases. Urban areas in India are examples found in this stage. Norway, as a 
Western European country is in the fourth stage of the transition where efforts aimed to prevent, 
diagnose and treat CVDs have been able to delay the development of these diseases (Yusuf, S. et 
al. 2001). The number of deaths caused by CVD in Norway has decreased during the last 
decades, but CVD is still accounted as the leading cause of death on a national basis (Statistics 
Norway 2010c). A fifth stage of the epidemiologic transition has also been proposed for 
countries where war or social upheavals destroy the existing social and health structures of the 
society leading to reoccurrence of communicable diseases (Yusuf, S. et al. 2001). 
CVDs are no longer only “Western diseases” although many may still have this notion. The 
trend has changed implying that the poorer and less developed countries are disproportionally 
affected carrying the greatest burden of CVD mortality; 82 per cent of the CVD deaths occur in 
low-and middle income countries (WHO 2011a). An additional concern is the fact that people in 
developing countries often die younger than in developed countries (WHO 2003). These 
countries are still struggling with communicable and deficiency-related diseases while being 
more exposed to CVD risk factors than developed countries (WHO 2011a). This is referred to as 
a “double burden” meaning that poorer countries are greatly exposed to both traditional risk 
factors and the risk factors associated with chronic diseases and their consequences (Mackay et 
al. 2004).  
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CVD may lead to disability and long lasting complications. In order to measure the burden of 
CVD not only through mortality numbers, it is possible to include the burden of disease using the 
concept of DALYs (Disability Adjusted Life Years). DALYs represent a statistical concept 
developed to accommodate the measuring of additional health aspects and to compare them 
across populations. DALYs combine the number of potential years lost due to premature death 
and years of productive life lost due to disability. This means that one DALY represents one lost 
year of healthy life (WHO 2003).  It is estimated that 18 % of DALYS in high income countries 
are due to CVD, while the equivalent number is 10 % for low and middle income countries 
(Mackay et al. 2004). This reflects that people live longer with these diseases in higher income 
countries where the access to treatment and prevention efforts are improved. 
1.3  Equality and equity in health  
The definition of health stated by the WHO, in the preamble to its constitution, was further 
underlined as a basic human right. It stated that every human being has the right to enjoy “the 
highest attainable standard of health”. The highest attainable standard sound as a diffuse measure 
of health, but can more specifically be understood as reflected by the standard of health enjoyed 
by the most socially advantaged groups in a society (Braveman & Gruskin 2003).  
Equity in health has become an increasingly important focus in the field of public health and 
health promotion, both nationally and internationally (Elstad 2005; Klepp 2010; Marmot et al. 
2008). In Norway this is now evident in the political processes, referring to a new public health 
law which, among other things, aims at reducing social inequalities in health (Prop. 90 L (2010-
2011)). It is noted that the concept of equity is different from the concept of equality. Equity is 
both an ethical and value-laden word which includes aspects of justice and fairness in the sense 
that it addresses inequalities considered both unnecessary and avoidable (Braveman & Gruskin 
2003). Efforts striving to achieve equity in health are moreover, based on an aspiration to fulfill 
the public health potentials (Braveman et al. 2011). Achieving equity in health demands 
identification and examination of health inequalities before interventions addressing root causes 
can be added (Whitehead et al. 2001). 
A social model of health is based on a holistic understanding of the health concept, and points 
out how different determinants in the surrounding environment can impact on the health of an 
individual. This model of health is opposed to the medical model which solely emphasizes the 
presence or absence of disease determining a person’s health (CDHN s.a.; Naidoo & Wills 
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2000). The rainbow showing modifiable layers of influence on health (Figure 1) explain how 
health is a result of complex interaction between personal, social, economic and environmental 
factors.  
 
Figure 1: Dahlgren & Whiteheads social determinants of health rainbow (Whitehead et al. 2001).  
Despite the increasing focus on equity; systematically inequitable distribution of social 
determinants can be found in many societies today (Braveman & Gruskin 2003; Marmot 
2007).Differences do not only exist between countries (as explained in section 1.2.), but also 
within countries. Well documented is the so-called “social gradient” identified in several 
countries including Norway (Braveman et al. 2011; Claussen & Naess 2002; Phillimore et al. 
1994; Strand & Tverdal 2004). This gradient implies that low socioeconomic status (SES), 
indicated by occupation, education and income, functions as a strong risk factor for mortality and 
morbidity in general, as well as for CVD mortality and morbidity in particular (Elstad 2005). 
With higher SES follows correspondingly a better health status and lower overall mortality found 
in each step of increased SES. This gradient may also play a role in health disparities according 
to ethnic belonging; identified as another important structure of the society impacting on general 
and cardiovascular health (Bhopal 2007). The relationship between ethnicity and health is still 
difficult to understand and it has been stressed that extensively more research is required in order 
to intervene on such health inequalities (Liburd & Jack 2005). 
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1.4 Ethnicity and CVDs  
As is being explained more thoroughly in the article, several studies have previously shown that 
ethnicity affects the risk of developing CVD (Anand et al. 2000; Chaturvedi 2003; Grundy et al. 
1999). Ethnicity may appear as an independent determinant or risk factor for disease without 
regard of the main risk factors (Grundy et al. 1999). It is disputed, however, whether ethnicity is 
a risk factor per se or if ethnic belonging put people at risk through other factors (Kain & Catto 
2002; Nazroo 1998). What direction the risk is affected also varies based on the different ethnic 
groups and the type of disease in question (Chaturvedi 2003; Khan et al. 2004). Bhopal (2007, 
p.63) has stated that variation in disease and risk factors based on ethnicity may be even greater 
than variations based on more common epidemiological variables such as gender and 
socioeconomic status. It is therefore important not to ignore such differences, but to include them 
alongside with other epidemiological variables striving towards a better understanding of the 
underlying mechanisms for inequality in health.   
Ethnicity versus race 
When addressing differences in health, ethnicity is often the preferred exposure variable before 
race. Ethnicity is a complex concept including more aspects than that of race, although the 
concepts are overlapping and often used synonymously. Race is, more often than ethnicity, used 
to divide people according to their physical features and consequently ignores differences in 
environmental, social and economic circumstances. The concept of race is also encumbered with 
a history that associates it with misuse, in terms of ethnocentricity and racism (Bhopal 2007). 
Though the concept of ethnicity can be comprehended as both subjective and social, it is also 
related to birthplace and national origin which is one of the common ways of dividing people 
into ethnic groups (Bhopal 2007). 
1.5 Immigrants in Norway 
More than eleven per cent of the Norwegian population consists of people who have either 
immigrated to the country themselves (first-generation immigrants) or who have been born in 
Norway by two parents who immigrated (second-generation immigrants). There are immigrants 
in all counties, though the largest share lives in Oslo. The immigrants in Norway originate from 
215 different countries; most of them from Poland, Sweden, Germany and Iraq. Among the 
largest groups are also Pakistan and Somalia if including second generation immigrants 
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(Statistics Norway 2010c). About 24 % of all immigrants who arrived in Norway during 1990-
2008 came as refugees, another 24 % came as labour immigrants and 11 % to acquire an 
education. Additionally, 23 % came to Norway to reunite with their families and 17 % got 
residence permit because they had established a family (Statistics Norway 2010c). During the 
last twenty years, the share of immigrants (both first- and second generation immigrants) 
migrating from Asia, Africa, Latin-America and Turkey has increased (Statistics Norway 
2010b). The total number of immigrants is suggested to increase further. Statistics Norway did a 
projection which predicts an increase from 460 000 first-generation immigrants in 2010 to 1-1,8 
million first-generation immigrants in the year of 2060. Additionally, second generation 
immigrants will increase, implying that 22-28 per cent of the Norwegian population will be of a 
non-Norwegian ethnic origin in only fifty years to come (Statistics Norway 2010a). During 2010, 
the number of immigrants have already changed from 460 000 to 600 900 (Statistics Norway 
2011). These numbers illustrate the importance of focusing on public health challenges relevant 
for a multiethnic society. 
 
1.6 Cardiovascular diseases  
CVD belongs to the group of non-communicable diseases and consists of different diseases and 
illnesses with different outcomes, all related to the heart and blood vessels. These diseases are 
(Mackay et al. 2004; WHO 2011a):  
 Coronary heart disease (CHD) which is also termed ischemic heart disease (IHD) (Burns 
& Kumar 2003). This is a disease of the vessels supplying the heart, of which heart attack 
is a potential outcome. 
 Cerebrovascular disease which is a disease of the vessels supplying the brain. Stroke is a 
potential outcome. 
 Peripheral arterial disease which is a disease of the arteries supplying the legs and arms. 
 Rheumatic heart disease involves damage to the heart muscle and valves following a 
streptococcal bacterial infection causing rheumatic fever.  
 Congenital heart disease involves malformations of the heart structures already existing 
at birth. 
 Deep vein thrombosis with possibly following pulmonary embolism (blood clots in the 
leg veins which can possibly dislodge and end up in the heart and lungs). 
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Cerebrovascular disease and ischaemic heart disease are the two diseases mainly responsible for 
CVD being the leading cause of death (WHO 2009).  
1.6.1 Pathogenesis and risk factors  
CVD is a multifactorial disease where different factors interact with each other in a 
multiplicative way creating atherosclerosis, which is the main underlying pathophysiologic 
mechanism (Kannel et al. 1976; Schoen & Cotran 2003). Congenital heart disease and rheumatic 
heart disease are of course exceptions with other specific causes, as described above. 
Atherosclerosis develops over years and is caused by deposits of plaque in the inner artery walls 
consisting of lipid, cholesterol, calcium and some other components. This plaque results in a 
hardening and thickening of the artery wall which can lead to a narrowing of the lumen that 
reduces the blood flow, or rupture of the plaque causing thrombosis (blood clot). This can 
eventually result in a blockage of the blood supply to the heart or brain, resulting in either a heart 
attack (myocardial infarction (MI)) or stroke (cerebrovascular infarction) depending on which of 
the two organs is affected (Remaley et al. 2005; Schoen & Cotran 2003). Stroke might also occur 
if a blood vessel ruptures creating bleeding into the brain (Mackay et al. 2004) . The complex 
medical mechanisms will not be discussed in more detail since that is too extensive for the 
intention of this paper.  
Many risk factors for CVD have been identified, in fact more than 300 different risk factors are 
said to be associated with CVD. It is also stated that about eighty per cent of the coronary heart 
and cerebrovascular disease cases is mainly a result of behavioral risk factors (WHO 2011a). The 
most important behavioural risk factors are unhealthy diet, physical inactivity and smoking. The 
effects of behavioural risk factors can further be seen in individuals as increased blood pressure, 
increased blood sugar levels, increased levels of lipids in the blood, overweight and obesity. 
These effects are called intermediate risk factors because they are results of primary risk factors 
while still functioning as independent risk factors for CVD outcomes (WHO 2011a).  The 
intermediate risk factors have a more direct effect on the atherosclerotic process (WHO 2009). 
The relationship between primary and intermediate risk factors is illustrated in Figure 2. Other 
risk factors not preventable are increasing age, male gender, family history and genetic 
disposition (Schoen & Cotran 2003). 
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Figure 2: A simplified illustration of the causal chain in developing CVD 
(Kjersti Stormark Rabanal) 
 
Based on the fact that current knowledge on most important risk factors is derived from 
developed countries, Yusuf et.al. (2004) carried out a standardised case-control study of acute 
myocardial infarction (MI) in 52 countries represented by all inhabited continents of the world. 
This study concluded that nine risk factors accounted for most of the risk of MI in both sexes, in 
all ages and in all regions. The risk factors (abnormal lipids, smoking, hypertension, diabetes, 
abdominal fat, diet patterns, activity-level, alcohol and psychosocial factors) can consequently be 
held as risk factors in different ethnic groups (Yusuf et al. 2004). 
1.6.2 Short description of some risk factors  
Smoking 
Smoking is a well-documented risk factor for CVD and no safe level has been identified (Schoen 
& Cotran 2003; Yusuf et al. 2004). Cessation is therefore recommended for all smokers. 
Smoking harms the cardiovascular system in several ways. In example, smoking leads to raised 
blood pressure, reduces the oxygen supply to the tissue and reduces the tolerance of physical 
exercise as well as contributing to atherosclerosis by increasing the clotting of the blood (AHA 
2011). 
 
Poor household economy 
and low education level, 
combined with low prices 
on unhealthy food 
products 
Unhealthy diet 
Increased blood 
glucose and 
blood lipids, 
overweight 
CVD 
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Blood pressure 
High blood pressure (hypertension) changes the structure of the arteries (WHO 2009) and is an 
important risk factor for developing several cardiovascular diseases such as cerebrovascular 
disease, ischaemic heart disease, and heart failure. Diet, especially one with high contents of salt 
and saturated fat, alcohol, lack of exercise, overweight  and stress are factors that raise the blood 
pressure (Whitworth 2003; WHO 2009). However, more than 90 % of the cases of hypertension 
do not have a clear cause (Oparil et al. 2003). Definitions of hypertension differ according to 
where and when (daytime/nighttime) it is measured.  Blood pressure measured at the doctor’s 
office is expected to be slightly raised due to a so-called “white coat effect”. Office hypertension 
is therefore defined as ≥140/90 mmHg as opposed to ≥135/80 if it had been measured at home 
(Mancia et al. 2007).  
Diabetes and blood glucose 
Diabetes mellitus is a chronic disorder of the metabolism of carbohydrate, fat and proteins. It is 
characterized by a relative or absolute deficiency in secretion or action of insulin; an anabolic 
hormone essential for controlling the glucose (sugar) levels in the blood by permitting cells to 
use glucose for energy (Clare-Salzler et al. 2003). Consequently without insulin, the blood 
glucose persists in the blood, leading to raised levels, also referred to as hyperglycemia (Freeman 
2005). Diabetes is classified into two major variants; type 1 and 2 (although other variants exist). 
Type 1 is characterized by autoimmune destruction of the insulin-producing cells in pancreas. 
Type 2 generally has its outset in higher age, and is characterized by insulin resistance and 
defective insulin secretion. The latter constitutes the majority of the cases (Freeman 2005). 
Although the two types are different both in pathogenesis and metabolic characteristics, they 
both have increasing effect on the risk of CVD. Genetic factors play a central role in the 
development of both types (Clare-Salzler et al. 2003). In those genetically susceptible, changes 
in diet, increasing age, obesity and reduction in activity levels increases insulin resistance and 
thereby the risk of diabetes type 2 (Freeman 2005; WHO 2009). It is noted that hyperglycemia is 
an independent risk factor for CVD whether the individual has diabetes or not (WHO 2009), the 
mechanism for how it induces atherosclerosis are complex (Aronson & Rayfield 2002). 
Blood lipids and lipoproteins 
The lipids (fats) in the blood are transported as lipoproteins, attached to specific apolipoproteins 
(Schoen & Cotran 2003). Both lipids and lipoproteins are related to CVD with important effects 
on the atherosclerotic process (Schoen & Cotran 2003). High levels of lipids, such as 
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triglycerides and cholesterol, have been held as independent risk factors for CVD (Castelli 
1996). However, the independend role of triglycerides is somewhat debated; it is unclear whether 
the relation with CVD is primarily direct or indirect (Cullen 2000). Moreover, triglycerides have 
traditionally been measured fasting, but there are increasing indications about imposed risk from 
non-fasting triglyceride levels as well (Bansal et al. 2007). Special emphasis, regarding high 
levels of lipids, has been put on cholesterol which is a well-documented independent risk factor 
for CVD (Bansal et al. 2007; Schoen & Cotran 2003). Yet, focusing on lipids is not enough 
when assessing risk, since the lipoproteins play an important role. Important lipoproteins 
include; high density lipoprotein (HDL), very low density lipoprotein (VLDL) (rich in 
triglycerides) and low density lipoprotein (LDL) (rich in cholesterol and a result of metabolised 
VLDL) (Despopoulos & Silbernagl 2003). HDL is often considered “the good” cholesterol and  
LDL the “bad” based on their effect on atherosclerosis, although this is an oversimplified 
statement since lipoproteins are transporters of lipids and consist of more than cholesterol 
(Biggerstaff & Wooten 2004). HDL cholesterol cleans up excess cholesterol and transports it 
from the tissue to the liver (Remaley et al. 2005). The ratio between total cholesterol and HDL 
cholesterol has been found to be a good predictor of the risk (Castelli 1996). Lipids are both 
made in the body and obtained from food (Mackay et al. 2004). Examples of factors that 
increases the levels of lipids in the blood are diets high in saturated fat and cholesterol, lack of 
physical activity as well as genetics (WHO 2009). 
Overweight/obesity 
Overweight and obesity is defined as “abnormal or excessive fat accumulation that may impair 
health” (WHO 2011b). The causes of obesity are not completely understood, and genetic factors 
as well as environmental and psychological factors play a role. Obesity leads to hypertension, 
diabetes, hypertriglyceridemia and it decreases HDL (Schoen & Cotran 2003). The body mass 
index focuses on the relation between weight and height, and is used to define overweight and 
obesity. Calculation of BMI is described in the article. A BMI of ≥25 is defined as overweight 
and ≥30 as obesity. The definition of overweight has been questioned in relation to Asian 
populations. This was addressed by an expert consultation of the WHO, who found that the 
observed health risk varied from a BMI of 22-25 in different Asian populations. The consultation 
consequently concluded that the international cut-off should be maintained for all populations 
(WHO 2004). Other than BMI, the waist to hip ratio (WHR) can help accommodate 
identification of excessive abdominal fat distribution, which is, in particular, a strong risk factor 
for CVD (WHO 2000). Which measure of overweight is best in relation to risk of CVD, has been 
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disputed, but Dalton et al. (2003) found that the WHR was somewhat preferable to BMI and 
waist circumference alone, although all measures showed predictive values in relation to type 2 
diabetes, hypertension and dyslipidemia (Dalton et al. 2003). 
 
1.7 Total risk versus high levels of single risk factors  
Based on the interaction between risk factors, total risk scores have been derived to account for 
the total risk, not able to assess through focus on single risk factors (Kannel et al. 1976). The 
interaction between the risk factors means that when several risk factors appear together they 
increase the effect of each other (Norheim et al. 2009).  
1.7.1 Systems established for assessing total risk 
The Framingham Heart Study is a cohort-study which started in 1945 (Framingham Heart Study 
2011b), and has contributed with important knowledge about risk factors for CVD. The study 
has its’ name after the American city where participants were recruited. Based on that specific 
population, the findings of the study are mostly representative for white, American populations. 
Yet, many findings are appraised as fundamental and internationally valid (Framingham Heart 
Study 2011b). For example, the Framingham Heart Study is the one that identified the main risk 
factors for CVD (Framingham Heart Study 2011a) and several risk score equations have been 
established based on the Framingham Heart Study. Such equations calculate a person’s risk of 
CVD events, based on an individuals’ values of different risk factors (Anderson et al. 1991a; 
Anderson et al. 1991b; D'Agostino et al. 1994; D'Agostino et al. 2008; Kannel et al. 1976; 
Kannel et al. 1999; Wilson et al. 1998). The Framingham equation chosen for this study 
calculates 10-year risk of general CVD (including both fatal and non-fatal events) based on the 
risk factors age, gender, total cholesterol, HDL cholesterol, treated and untreated systolic blood 
pressure, smoking and diabetes (D'Agostino et al. 2008). 
Framingham risk equations were previously used in European context, but in 2003 the European 
Society of Cardiology (ESC) made a new recommendation (De Backer et al. 2003). This new 
recommendation implied shifting to another system called SCORE (the European Systematic 
Coronary Risk Evaluation), because Framingham equations had a tendency to overestimate the 
risk of CVD in populations with generally lower risk, especially in the more southern parts of 
Europe (Conroy et al. 2003). The SCORE-project started in 1994 and resulted in a total risk 
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score system considered more valid for European populations (De Backer et al. 2003; Sleight 
2002). 
However, a general problem using SCORE is that it is based on the cardiovascular mortality 15-
20 years ago. The model has therefore been found to overestimate the risk of CVD mortality in 
Norway (Lindman et al. 2006; Lindman et al. 2007). Based on this fact, Selmer and co-workers 
developed a new model for estimating risk, called NORRISK (also referred to as SCORE 
Norway). This model is calibrated according to the level of mortality in Norway during the time 
period of 1999-2003. It is based on numbers on mortality from Statistics Norway, mortality 
follow-up from Norwegian cardiovascular surveys and levels of risk factors from regional health 
examinations. NORRISK estimates 10-year risk of death from CVD based on the risk factors 
age, gender, systolic blood pressure, total cholesterol in serum, and smoking. This model is more 
applicable for the Norwegian population than the original SCORE model (Selmer et al. 2008). 
Because NORRISK focuses on mortality instead of morbidity, age becomes a more significant 
risk factor in NORRISK than it does in Framingham (Norheim et al. 2009). 
The Norwegian Directorate of Health recommends application of NORRISK to asymptomatic 
persons who present with high levels of risk factors, have family members with early established 
CVD or present other reasons for calculating their total risk score. It is further noted that other 
risk factors which are not included in the equation must be considered additionally when 
assessing risk (Norheim et al. 2009). 
 
1.8 Aim of the study 
The aim of this study is to examine the relationship between cardiovascular health and ethnic 
origin. This will be done by investigating differences in cardiovascular risk factors and total risk 
scores among people originating from different geographical regions, living in Norway. 
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2.0 Material and methods 
The material and methods are described in the article (starting page 3), and only the most 
essential parts will therefore be summarized here. Additional considerations not described in the 
article will also be accounted for. The relevant part of the questionnaire used in CONOR can be 
found in appendix I. 
 
2.1 Summary of method 
This study used data from the Cohort of Norway (CONOR) which is a large database constituted 
of ten regional health surveys. These surveys were not explicitly mentioned in the article, and 
will therefore be summed up here. CONOR includes the following (Næss et al. 2008);  
- The Tromsø Health Study (Tromsø IV and V)  
- The Troms and Finnmark Health Study (TROFINN) 
- The Nord-Trøndelag Health Study (HUNT II and III) 
- The Oslo Health Study (HUBRO) 
- The Second Oslo Study (Oslo II) 
- The Oslo Immigrant Health Study (I-HUBRO) 
- The second part of the Romsås in Motion Study (MORO II)  
- The Oppland and Hedmark Health Study (OPPHED)  
- The Hordaland Health Study (HUSK)  
We restricted the sample to the first time subjects participated in a CONOR-survey, and thereby 
excluded participants who were registered for the second or the third time (Næss et al. 2008). 
The CONOR-sample totally consists of 174 430 individuals. 
The design of this study is cross-sectional aiming to examine ethnic differences in cardiovascular 
risk factors and total cardiovascular risk according to the NORRISK and Framingham equations 
described in the article and mentioned in section 1.7. Eleven different ethnic groups living in 
different parts of Norway were compared holding birth place as an indicator of ethnic belonging. 
This included Norwegian-born residents and people who had immigrated from the regions; 
Eastern Europe, Former Yugoslavia, North Africa, Sub-Saharan Africa, the Middle East, the 
Indian subcontinent, East Asia, North America, South America and South-East Asia.  
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The sample was restricted according to exclusion criteria related to selected regions and 
plausible values of risk factors included in the total risk score systems. This resulted in a main 
sample of 62 145 (53 % women) participants in the age range 40-65 years old. Further 
exclusions were subsequently performed according to exclusion criteria for the two risk score 
equations, which resulted in two smaller samples; one for each equation.  
Differences between the groups were examined stratified by sex and adjusted for age using one-
way analysis of variance by applying a generalized linear model. Glucose and triglyceride 
estimates were additionally adjusted for time since last meal. The PASW Statistics version 18 
was used for all analyses. Post-hoc tests were done for the risk scores when significant overall 
differences between the ethnic groups were found. Such post-hoc tests involved comparing the 
immigrant-groups to Norway, which was held as reference. P-values less than 0,05 were 
considered statistically significant. 
It is added that the definition of high total cholesterol/HDL ratio used in the article was based on 
studies referring to the predictive value of this ratio in relation to coronary heart disease 
(Kinosian et al. 1994) as well as the threshold found in the Norwegian electronic  medical 
handbook (NEL- Nevrologiske Prosedyrer 2001). 
 
2.2 Additional information about the sample  
As mentioned in section 1.5, most of the immigrants in Norway live in Oslo. Correspondingly, 
immigrants in this study were best represented through the Oslo-surveys (containing 73 % of all 
immigrants in the sample). Naturally I-HUBRO was the one with most participants born outside 
of Norway since I-HUBRO only included people born in Turkey, Iran, Pakistan, Sri Lanka and 
Vietnam (NIPH 2005). 
Although we did not know the single birth country that each participant originated from, it was 
possible to see who had participated in the Oslo Immigrant Health Study and get an idea of how 
some of the countries were represented. In our main sample of 62 145 participants, 385 (55 %) of 
the 669 people coming from the Middle East participated in the Oslo Immigrant Health Study 
and was therefore either Turkish or Iranian (the only two Middle East countries represented in I-
HUBRO). Correspondingly, 507 people (47 %) of the 1071 from the Indian subcontinent in our 
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sample were immigrants from either Sri Lanka or Pakistan, and 259 (42 %) of the South East 
Asian group of 611 individuals were Vietnamese. 
 
2.3 Additional considerations: choosing birth regions 
The total population in CONOR originated from 16 different birth regions, and in addition to the 
regions that were included and mentioned above; Western Europe, The Pacific, Central America, 
Oceania/Pacific and Central Asia were among those.  
Western Europe was left out because it was considered as similar to Norway and we wanted to 
limit the number of groups. The other four regions were excluded because they constituted small 
samples. 
2.3.1 Checking the possibility of merging some birth regions  
When choosing the birth regions, the possibility of merging some of them into larger regions was 
examined. The intention of merging was to preserve a large sample size (groups with few 
representatives could be included in the study if merged into larger regions) and give a better 
overview having fewer groups. Examining this possibility meant examining differences in risk 
factors between the two groups in question. If no significant difference in important risk factors 
were found, then merging would be conceivable. Otherwise, the groups with very few 
representatives would be excluded. Groups that were considered as possible to unify were those 
considered close in a geographical sense; Eastern Europe (n=405) with Former Yugoslavia 
(n=341), Central America (n=55) with South America (n=243), and East Asia (n=225) with 
South-East Asia (1272). When examining the possibilities, independent samples t-tests were 
performed to check for significant differences in the mean values of important risk factors. 
Regression analysis to adjust for age and gender were then performed to control for possible 
confounding.  
Eastern Europe and former Yugoslavia  
Independent sample t-tests showed that Eastern Europe was significantly different from former 
Yugoslavia in several of the risk factors. Differences were found in triglycerides (mean 
difference = -0,259 mmol/L, p=0,004), HDL (mean difference = 0,277, p<0,001), BMI (mean 
difference = -1,28, p<0,001), WHR (mean difference = -0,024, p<0,001) and age (mean 
difference = 7,05 p<0,001). The differences found in triglycerides, HDL and age were 
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considered most important since these were to be included in risk score calculations later. HDL 
has different recommendations based on gender (Mackay et al. 2004) and it was therefore 
decided to control for gender when evaluating the differences found in the t-test. Age was also 
included as a possible confounder. A linear regression analysis showed that these birth regions 
had a significant effect of 0,334 mmol/L on triglycerides (p<0,001) when controlling for age and 
gender. Combining these two regions was therefore out of the question since that would have 
increased the heterogeneity in such a hypothesized merged region. A regression analysis was not 
performed to control the difference in HDL and age since the difference in triglycerides was 
already found significant when controlling for age and gender. 
Central America and South America 
The significant differences in risk factors between Central America and South America revealed 
in an independent sample t-test, was a mean difference of 0,136 mmol/L in HDL (p=0,015) and a 
mean difference of 4,64 mmHg in systolic blood pressure (p=0,05). As mentioned above, HDL 
levels vary based on gender, and a following regression analysis showed that these birth regions 
had an effect of -0,106 mmol/L when controlling for age and gender which was statistically 
significant (p=0,046). Gender also had a significant (p < 0,001) effect of 0,250 mmol/L on HDL-
levels in the same regression analysis. Different gender distribution in the two countries might 
therefore be responsible for some of the difference found as significant in the t-test, knowing that 
the effect of gender was larger and significant on a higher level than that of birth regions. 
Women constituted 66 % in the group originating from Central America and 55 % in the group 
from South America. It was decided to exclude Central America to avoid increased 
heterogeneity. In a possibly merged region, South America would in any case have been the 
predominating group with more than four times the number of representatives than of Central 
America.  
East Asia and South-East Asia 
T-tests checking for differences in mean values of risk factor between East Asia and South-East 
Asia showed statistically significant differences in triglyceride and HDL levels. The mean 
difference in triglycerides was -0,212 mmol/L (p=0,006) while the mean difference in HDL was 
0,089 (p=0,001). A following regression analysis controlling the difference in triglycerides for 
age and gender, showed that these birth regions had a statistically significant effect of 0,032 
(p=0,009). This finding excluded the possibility of merging the two regions.  
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3.0 Ethics 
This study is in accordance with the World Medical Association Declaration of Helsinki; a set of 
ethical principles regarding medical research that involves human subjects (WMA 2008). All the 
participants in CONOR signed a written informed consent form (Næss et al. 2008). The data was 
made unrecognizable by the CONOR Steering Committee before access to the data was 
acquired, and the project protocol has been evaluated by legal employers at the Norwegian 
Institute of Public Health (NIPH). All the studies in CONOR have been approved by the 
Norwegian Data Inspectorate and evaluated by the Regional Committees for Medical Research 
Ethics (Søgaard 2007).  
Focusing on ethnicity in research also requires some ethical considerations (Ingierd & Fossheim 
2009). In this study, the concept of ethnicity has been chosen before the concept of race; in part 
because it is apprehended as less potentially offensive. As mentioned earlier, research on race 
and ethnicity has historically been unethically carried out. It is therefore required to show caution 
in the interpretation and presentation of findings - which has been attempted here (Ingierd & 
Fossheim 2009). It is further noticed that when dividing people into groups as was done here, 
there are possibilities of creating or supporting stigmatization, although that is not the intention. 
Research on ethnicity and health is important, and not taking ethnic differences into 
consideration would also be unethical (Bhopal 1997). The intention of this study is that ethnic 
groups might benefit in the future. 
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4.0 Results 
The results were explained in the article and will therefore briefly be summarized here.  
 
4.1 Summary of results 
The analyses of variance showed significant differences in risk factors, and in total 10-year risk 
of general CVD based on the Framingham equation, between ethnic groups. This was observed 
in both men and women. Differences in total 10-year risk of CVD mortality using NORRISK 
was, however, only observed in men. Most of the groups showed high levels of inactivity, 
highest in immigrant groups from less developed regions. 
Immigrants from countries of the Indian subcontinent showed the highest prevalence of diabetes, 
the highest levels of blood glucose, WHR, triglycerides and the lowest HDL cholesterol levels. 
This group also had the third highest score in total risk of general CVD. 
Immigrants from the Former Yugoslavia showed high levels of several risk factors and had the 
highest total risk of general CVD according to the Framingham equation. This applied to both 
men and women. Regarding risk factors, Former Yugoslavians had the highest total 
cholesterol/HDL ratio and high levels of blood pressure, overweight indicators and smoking.  
North Americans were the highest educated group in this study sample and showed relatively 
low levels of several risk factors. East Asia showed lower total risk score according to 
Framingham, and low levels of overweight measures and lipids. 
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5.0 Discussion 
The results were discussed in the article and will therefore not be discussed in detail here. In 
addition to a discussion of methodological considerations, I will discuss the findings in a larger 
context underlining their relevance to the field of public health. 
 
5.1  Methodological considerations 
This is a cross-sectional study where all the information about the participants refers to one point 
in time (Rothman 2002). In this case; the first time the subjects participated in a CONOR survey. 
Associations may be assessed in cross-sectional studies, but no causal conclusions can be drawn 
(Rothman 2002).  
5.1.1  Errors affecting reliability and validity 
Two types of error are of general concern in epidemiologic studies; random error and systematic 
error (Rothman 2002). Random error represents stochastic variations in the data that cannot 
readily be explained by the researcher (Bjørndal & Hofoss 2008). Systematic error is also 
referred to as bias (Rothman 2002) and may be a problem if the research methods systematically 
afflict the results. These two types of error can influence the reliability and validity of the study. 
Reliability require accurate measurements, and is often defined as consistency of repeated 
measures (Aalen 1994; Winter 2000). The validity of a study demands reliable data, and further 
that what is actually measured corresponds with what was intended to be measured (Aalen 
1994).  
Uncertainty in the estimates caused by random error is, in this study, demonstrated by the 
application of confidence intervals and standard deviations in the tables of the article. CONOR 
contains a large number of participant data (Næss et al. 2008). This accommodates relatively 
large sample sizes which reduces the problem with systematic error. However, after exclusions, 
some of the groups ended up having relatively small sample sizes, which was further 
demonstrated by large confidence intervals. This was particularly evident in immigrant groups 
compared to Norway which had the largest sample size and greater certainty in its estimates. 
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Different types of systematic bias can be categorized into selection bias, information bias and 
confounding (Rothman 2002). The latter is of less importance here, since the multidimensional 
concept of ethnicity allows many aspects to explain causes for the differences found in the study.  
Selection bias is a possible problem that affects the external validity concerning transferability 
(Bjørndal & Hofoss 2008). The participation rate was lowest in Oslo and the urban areas and 
participation rate among immigrants was low in the Oslo Health Study (Næss et al. 2008; 
Søgaard et al. 2004). However, the CONOR-variables of age, sex, birth country, education and 
smoking have been found to correspond with the Norwegian population (Aamodt et al. 2010). In 
relation to the different ethnic groups, a phenomenon referred to as “the healthy migrant effect” 
imply that the immigrants might represent particularly healthy parts of the population in their 
country of origin (Fennelly 2007). 
An example of information bias includes possible under-reporting of self-reported variables, a 
possible cause for error of measurement in this study (Aamodt et al. 2010). A particular example 
is self-reported data on smoking, which may be encumbered with uncertainty as a consequence 
of underreporting (Patrick et al. 1994). Still, questionnaire information on chronic diseases have 
been found to be valid among patients with diabetes in Norway (Midthjell et al. 1992).  
Also regarding information bias and error of measurement is that some measurements are in 
general not always reliable. For example, blood pressure may vary based on who is performing 
it, the device and when or where it is measured (Aalen 1994). This was, to some extent, 
accounted for in CONOR by measuring the blood pressure after each subject had rested two 
minutes and then using three different measurements to calculate a more reliable blood pressure 
mean. The reliability of the measurements in CONOR has been somewhat secured by letting 
trained and experienced personnel conduct the procedures following a standard procedure in all 
the surveys (Næss et al. 2008). Moreover, although blood samples were analyzed at different 
laboratories, calibration procedures between the laboratories have been performed and the 
consistency of the analyses have been evaluated and considered acceptable.  
The application of large birth regions as indicators of ethnicity is an important question 
regarding the validity of this study. Do the birth regions actually reflect the participants’ ethnic 
belonging? A problem is that the regions are in all likelihood heterogeneous ethnic groups that 
include several ethnic subgroups varying in risk factors (Bhopal et al. 1999; Bhopal 2007; 
Nazroo 1998). However, this way of defining ethnicity may be an advantage in the sense that it 
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is relatively common, and therefore accommodates the possibilities of comparing with other 
studies. There is no current consensus on the most appropriate way to use the concept of 
ethnicity when linking it to differences in health. Yet, the currently preferred way of defining 
ethnic belonging seems to be that of self-assessment, but self-assessment may change over time 
and be even more fluent than other definitions (Bhopal 2007; Nazroo 1998). The birth regions 
applied here are therefore considered as relatively valid, though not ideal, indicators of ethnic 
belonging. 
5.1.2 The risk score equations; valid indicators of total risk for all ethnic 
groups? 
NORRISK was derived using mean mortality data in Norway and is meant for Norwegian 
populations (Selmer et al. 2008). It has not been validated for other ethnic groups. It is, however, 
the one recommended for national use (Norheim et al. 2009) and thereby relevant for all ethnic 
groups living in Norway. 
Some Framingham risk score versions (Anderson et al. 1991a; Wilson et al. 1998) are the ones 
that have been validated most for different ethnic groups compared to other available equations 
(Berger et al. 2010; Bhopal et al. 2005). Framingham derived equations have been validated in 
Caucasian Americans, African Americans, Europeans, and Mediterranean and Asian 
populations, but are less valid among some European and Asian populations. Some of the 
validations for different ethnic groups (living in the UK and the United States) have been done 
through recalibration using mean risk factor levels and ratio of survival estimates from minority 
cohort studies or prevalence data on different minority groups (Brindle et al. 2006; D'Agostino et 
al. 2001). 
The updated Framingham CVD equation applied here has not been validated in the same extent 
as older versions, but has been validated in Iranian (Bozorgmanesh et al. 2011) and Australian 
populations (Zomer et al. 2011) and was also found to be moderately effective in a population of 
the United Kingdom (Simmons et al. 2009) - although it overestimated the true risk in all the 
populations. The intention of calculating total risk in this study was not to recommend treatment, 
but to investigate differences based on ethnicity. It is therefore considered an advantage to apply 
this equation in addition to NORRISK, since it is more valid for different ethnic groups. 
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5.2 Ethnic inequalities in cardiovascular health - in light of the 
rainbow 
This study revealed ethnic inequalities in cardiovascular health indicated by important risk 
factors and calculated total risk scores. A fundamental question regarding social inequalities in 
health, is whether the causes lie in inherent or imposed characteristics, and if they are to be found 
in the individual or in social contexts (Krieger 2001). Are people from Former Yugoslavian 
countries genetically programmed to have poor cardiovascular health compared to other ethnic 
groups? Can the explanations be related to how the immigrants are welcomed and treated in the 
host country? Or perhaps psychological and behavioural effects of possible discrimination, 
combined with experiences before time of migration are more important? Moreover, it may be 
related to their cultural way of life, the type of food they eat and the way they prepare it. Possible 
answers are many, and uncovering all of them is not an object here. However, in the light of 
presented theory, I will suggest some circumstances that may contribute to unequal distribution 
of cardiovascular health determinants. This will be discussed in a wider sense than in the article, 
aiming to demonstrate the complexity of health inequalities and the need for a better 
understanding to finally address its root causes. The results from the cross-sectional study 
presented in the article will, however, form the basis for the discussion. 
The presented rainbow of the main determinants of health (figure 1 in section 1.3), shows how 
health is determined by a complex chain of causes.  
5.2.1 Age, sex & hereditary factors  
The inner layer of the rainbow of determinants is often considered as constituted by unalterable 
and predetermined factors. Increasing age leads to increased risk of CVD, and is the way of 
nature. Additionally, men are at greater risk of developing CVD than women, although women’s 
risk increases after menopause (Schoen & Cotran 2003). Whether individuals are born as a boy 
or a girl is not something they get to have a say in, and neither is the process of ageing. One 
simply has to accept genetics. Sex and age are both characteristics that unavoidably lead to 
inequalities in health, and following the definition of equity, these inequalities cannot be held as 
inequitable. They are unavoidable differences. The following question is then; are ethnic 
inequalities predetermined as functions of genetic characteristics and thereby also predetermined 
and unavoidable? Previous research focusing on racial (biologic) differences has tried to divide 
humans into sub-species, but have not succeeded doing so (Bhopal 1997). Research on ethnicity 
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has, as mentioned, historically been carried out with unethical intentions and researchers focused 
on racial differences in order to justify racial discrimination. Such researchers stated that biology 
determined social position, and thereby explained the differences through the viewpoint of 
biological determinism (Bhopal 1997). Although some genetic differences do exist, we are more 
alike than we are different, and it is not possible to say that different ethnic groups have 
completely different compositions of genetic characteristic (Bhopal 2007). A conclusion in the 
literature is also that modifiable factors are important for actual risk of CVD in all human beings 
despite possible differences in genetic susceptibility (Yusuf, Salim et al. 2001; Yusuf et al. 
2004).  
Although individuals cannot decide what genetics to be born with, genes are not unaffected by 
environmental conditions. This is reflected in theories of phenotype plasticity stated by 
evolutionary scientists (Via et al. 1995). “The thrifty phenotype hypothesis”, first proposed by 
Neel in the 1960’s (Neel 1962), is a relevant example in this context. The theory suggests that 
poor nutritional conditions experienced in early life, even as early as during gestation, may lead 
to a phenotypic adaption to poor nutritional conditions (Barker 2007; Bateson et al. 2004). Such 
adaption implies that the individual becomes better adapted to environmental conditions similar 
to what was experienced and “forecasted” in early life. The adaption consequently results in the 
individual being born with a smaller body and a modified metabolism that copes better when 
there is a shortage of food (Bateson et al. 2004).However, when the individual is brought up in 
affluent environments with excess of food, as is often the case in developed countries, this thrifty 
phenotype may lead to increased risk of coronary heart disease, type 2 diabetes and hypertension 
(Bateson et al. 2004). Many researchers have focused on such associations, and the Norwegian 
doctor Anders Forsdahl was one of the first to suggest that poor conditions in early life could 
lead to increased risk of CVD in later life. This was based on his findings of associations 
between infant mortality rates and later mortality of CVD among men in Finnmark (Forsdahl 
1977; Vangen et al. 2005).  Later researchers such as David J.P. Barker, although focusing on 
fetal conditions and the risk of CVD (Barker & Martyn 1992), found support for the findings of 
Forsdahl. The thrifty phenotype hypothesis, sometimes referred to as the “Barker hypothesis” 
has gained support in many different populations across the world (Hales & Barker 2001). It is 
one of the possible hypotheses that may explain some of the excess risk of diabetes and other 
metabolic disturbances for immigrants from the Indian subcontinent (Bavdekar et al. 1999; 
Yajnik 2001) found in this study.  
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Similar adaptive mechanisms have also been proposed for explaining some of the excess risk of 
hypertension in immigrants from the African continent due to a salt-sensitivity originally 
favourable for their forefathers living in hot and dry climates (Adair & Prentice 2004; Weder 
2007). However, in this study, only the female part of the group from Sub-Saharan Africa 
seemed to be in comparative high risk of hypertension. The thrifty phenotype hypothesis does 
further not only function as a possible explanation of increased risk in individuals migrating 
from less developed to more developed countries. It may also explain some of the increasing risk 
experienced in developing countries as a consequence of urbanizations and rapid epidemiologic 
transitions leading to more affluent societies (Yusuf, S. et al. 2001). 
5.2.2 Lifestyle 
More than eighty per cent of all the CHD and cerebrovascular diseases are said to be 
consequences of behavioural risk factors which implies great possibilities for prevention. It also 
suggests that focusing on individual behavior is important. Behavioural risk factors are likely to 
play an important role in all ethnic groups (Yusuf, Salim et al. 2001). The most important 
behavioural risk factors are as mentioned; diet, smoking and physical inactivity. According to the 
social model of health, however, individuals can only be held responsible for their own health as 
long as the access to a healthy life is equal and they are equally supported in making healthy 
choices (WHO 2005). It is therefore essential to examine whether ethnic groups in Norway have 
equal premises for adopting healthy lifestyles. 
Reasons for peoples lifestyles are complex; physical, mental, social and economic factors all 
play a part (Kerr et al. 2005). Immigrants in our study showed greater tendencies to physical 
inactivity than the Norwegian-born participants. This finding might correspondingly be due to 
different reasons. Factors that have been associated with behavioural cardiovascular 
determinants in other immigrant populations demonstrate the complexity. Some of the factors 
mentioned are; culture and belief, psychological fatalism, lack of knowledge about modifiable 
risk factors, mental reactions to both experienced and expected discrimination as well as less 
advantaged neighbourhoods (Evenson et al. 2004; Kandula et al. 2010; Williams 1998). Hence, 
some of the obstacles for healthy lifestyles seem to be linked to the fact that ethnic minority 
groups represent vulnerable groups in societies (Yassi et al. 2001).   
Social structures in relation with behavior is understood not only in terms of putting constraints 
on the individual, but also by functioning as enabling, influencing and motivating (Siegrist & 
Marmot 2004). The experiences of a positive self in individuals, in particular self-efficacy and 
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self-esteem, have been identified as important factors for a person’s motivation and disposition 
for healthy behaviour (Bandura 1977; Siegrist & Marmot 2004). A social structure that excludes 
individuals from belonging and taking part in the society as well as getting positive feedback, 
undermines the experiences of a positive self (Siegrist & Marmot 2004). Thus, integration of 
immigrants is essential when enabling people to adopt healthy lifestyles. Integration is a two-
way process (IMDi 2008) and can be defined as “harmonic co-existence with mutual exchange 
of culture and values” (Kogstad 2002, p. 136, own translation).  Although it is stated that the 
integration of immigrants in education and working life in Norway has had a positive trend the 
latest years, immigrants are still less employed, receive lower income and live in worse 
conditions than the Norwegian population as a whole (IMDi 2008). This is especially true in the 
immigrant groups where most have migrated as refugees. Many immigrants report that they have 
been discriminated when trying to get employed (IMDi 2008). Such experiences may be 
contributing to an absent experience of positive self and thereby obstructing motivations for 
healthy lifestyles.  
Lifestyle changes are the first choice in primary prevention and should be advised to all people 
with unhealthy lifestyle regardless of their risk of CVD. Unlike medical treatment, adopting a 
healthy lifestyle has no known adverse side effects, it is generally less expensive and rather add 
positive effects to a person’s physical and mental wellbeing (Whitworth 2003). In Romsås, 
Norway; a low-cost, population-based intervention program have shown positive effects on the 
physical activity level and other risk factors for CVD (Jenum et al. 2006). In the follow-up study, 
18 % of the participants were non-Western immigrants and the intervention was a 
comprehensive package of many different strategies taking a holistic approach, based on theories 
that included aspects of the participants experience of self, along with other important aspects of 
behaviour (Jenum et al. 2006). 
5.2.3 Social and community networks 
As mentioned in the previous subsection, belonging and participating in a society are important 
factors for positive experiences of self, and thereby for motivations for healthy lifestyles. 
Immigrants move from their countries for different reasons that involve different health 
challenges. Either way, migrating involves breaking up from social networks and starting over. 
Involuntary migration will, in particular, make readjustments even more challenging (Kogstad 
2002). The possible consequences of cultures that meet, in relation with immigration, are several 
(Berry 1997). Integration was defined in the previous section, and may further be understood as 
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participating in employment, education and the society in general, something that requires efforts 
from both the majority population as well as from the immigrants (IMDi 2008). How the 
immigrants adapt to the culture in the host society, highly determines their well-being and health 
through different ways of social interaction (Berry 1997; Kogstad 2002). 
After breaking out from social networks in the country of origin, lack of social networks is a 
possible consequence for immigrants. This can contribute making them more susceptible for risk 
of CVD since social networks accommodate the availability of social support, shown to have an 
important positive effect of several health aspects (Cohen & Wills 1985; Hånes 2008; Kessler & 
McLeod 1985). Since CVD is multifactorial, positive effects from social support on health in 
general may also apply for cardiovascular health in particular. Findings from the Oslo Health 
Study showed that the immigrants from low- and middle-income countries had less social 
support, less income and lessvpaid work than Norwegian born and immigrants from high-income 
countries. Lack of social support and social participation have been linked to CVD through 
possible pathways such as being stress-inducing and leading to unhealthy lifestyles (Dalgard & 
Lund Håheim 1998). In addition, circumstances like living alone, lacking a confidant, social 
isolation, low emotional support, low perceived support and lack of available support have in 
particular been shown to have a negative effect on the prognosis for people who have already 
experienced a CVD event (Rozanski et al. 2005).  
Immigrants in Norway may be exposed to discrimination and racism although the extent is 
unknown and difficult to measure (NOU 2002:12 2002). Discrimination and racism affect health 
aspects in a negative way both directly and indirectly (Williams 1999). In the United States, 
experienced racism have been associated with hypertension, increased psychological distress, 
depression, stress, poor self-rated health, higher number of smoked cigarettes, low birth weight 
in the children of the ones who experienced racism, and more reported days spent unwell in bed 
(Karlsen & Nazroo 2002). Social support was also suggested to mediate the relationship between 
racism and health (Karlsen & Nazroo 2002).  
5.2.4 Living and working conditions 
Living and working conditions influence health in various ways. In general, people need to work 
to earn money so that they can afford what they need to survive and stay healthy. Work may also 
influence the cardiovascular health of a person through psychosocial factors at the workplace 
(Karasek et al. 1981). As mentioned, immigrants in general are worse off when it comes to 
conditions in living and working, than the population as a whole. Immigrants in Norway 
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experience more lasting poverty than non-immigrants (Bhuller & Aaberge 2010) which might 
entail higher exposure of stressors that increases the risk of CVD (Elstad 2005; Rosengren et al. 
2004). The pathways for increased risk from stress may be both physiological as well as 
behavioural. In example stress, which occur when challenges are apprehended as too 
overwhelming for the individual to cope with (Folkman et al. 1986), can lead to increased blood 
pressure, increased blood glucose and unhealthy lifestyles (Elstad 2005; Surwit et al. 1992). 
The social gradient can be found in many ethnic groups, although not always similar - displaying 
a complexity in the association between SES and cardiovascular health. In some ethnic groups, 
the social gradient seems to be reversed. As an example, immigrants from Pakistan and Sri 
Lanka in the Oslo Immigrant Health Profile with the highest education reported about more 
psychological problems than people with low education – the opposite of other ethnic groups 
(Kumar et al. 2008). Similar reversed gradients were seen in Turkish and Iranians in relation 
with smoking (Kumar et al. 2008). This might be related to the epidemiologic transition, and 
which stage of the transition that the birth countries are in (Yusuf, S. et al. 2001). 
Smoking is suggested to be a behavioural risk factor that goes through four stages like an 
epidemic in populations; the association with education changing from the first to the last stage 
(Cavelaars et al. 2000). In the first stage, smoking is associated with higher SES, but in the last 
stage it is associated with lower. Norway and other North European countries, are now in the 
fourth stage where smoking is most prevalent in the lower SES (Elstad 2005; Strand & Tverdal 
2004). Immigrants may come from countries in earlier stages which might be the case with the 
Turkish and Iranians mentioned above (Cavelaars et al. 2000). Also pointed out is the fact that 
even if education is considered the most important indicator of SES in relation with CVD in the 
Nordic region (Norheim et al. 2009), it might be a poor indicator for immigrants knowing that 
highly educated immigrants in Norway are more likely to live in poverty than the highly 
educated non-immigrants (Bhuller & Aaberge 2010).  
Health care access is also an important determinant of cardiovascular health in populations 
(Bambra et al. 2010). In America, improvements in CVD have shown to be inequitable 
distributed among different racial and ethnic minorities partly due to poorer healthcare in the 
minorities than in Caucasian patients when controlled for income and insurance status 
(Ferdinand & Armani 2007). Inferior access or utilization of health care, following language and 
communications barriers may also be a challenge for immigrants in Norway (Larsen 2009). 
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5.2.4 General socio-economic, cultural and environmental conditions 
The epidemiologic transition serves as an illustration of the importance of the wider social, 
economic and environmental factors in public health. Changes in the environment and the level 
of development in a society, have shown to determine what type of risk factors populations are 
exposed to (Yusuf, S. et al. 2001). Following the globalization of today, epidemiologic transition 
in a country is not an isolated process, since migrants crossing borders might originate from 
countries in different phases of the transition. This outer layer of the rainbow impact on all the 
inner layers, and even our genetics seem to be affected -previously exemplified by the “thrifty 
phenotype hypothesis”.  
Social and economic contexts may influence on both the maintenance and creation of ethnic 
differences in health(Gushulak & MacPherson 2006). Addressing ethnic inequalities is therefore 
also a political concern. An example of this, and the fact that public health is a cross-sector 
responsibility, is the importance of public policies and taxations in influencing health behaviour. 
Smoking taxation, pricing, banning of both advertising and smoking in public places, are 
interventions that have shown to have an effect on reducing smoking symptoms or habits (Eagan 
et al. 2006; Fichtenberg & Glantz 2002; Hamilton et al. 1997; Saffer & Chaloupka 2000; Warner 
1986). In Britain, pricing policies were found to be especially effective on minimizing smoking 
prevalence among people in the lower socioeconomic groups, possibly due to their purchasing 
power (Townsend et al. 1994). This might imply that high prices on tobacco can help reduce the 
overall prevalence of smoking. It may also further contribute to reduce ethnic inequalities in 
CVD knowing that people with lower SES are most inclined to smoke, and immigrants more 
likely to be poor in Norway, both mentioned previously. 
Culture as one aspect of ethnicity, includes shared beliefs, values, customs and behaviours 
(Kuhrana 2007). Culture related to lifestyle is an important cardiovascular health determinant 
and may be responsible for some of the ethnic differences that were found in risk factors. An 
example of how culture can impact on health behaviour, is the religion Sikhism which prohibits 
consumption of smoking (Bhopal 2007). Culture may also be one of several explanations to why 
there are gender differences in smoking, as was evident in the results of our study (Grunberg et 
al. 1991). Diet, as another behavioural risk factor, is also related to cultural dimensions (Jackson 
1994). The culture may determine what kind of food is eaten, how it is prepared and so on. 
Larger social and economic factors related to the epidemiologic transition may also influence the 
culture and trends in nutrition in populations (Drewnowski & Popkin 1997). 
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The layers of the rainbow influencing health are interlinked and influence cardiovascular health 
in complex manners. It is underlined that this discussion of possible contributing factors to ethnic 
differences in cardiovascular health, is by no means thought of as exhaustive. Only a few of the 
many possible interacting factors have been mentioned here as examples of the existing 
complexity. 
Focusing on social and structural factors that creates health inequalities, as has been discussed, 
imply a redirecting of focus from individual factors towards “the causes of the causes” (Marmot 
2007). More research is needed in order to really understand the causal chain of existing 
inequalities in cardiovascular health, and it is important that research revealing differences 
among ethnic groups is not only put in the black box of epidemiology - which means that causal 
mechanisms behind associations remain hidden and not further investigated (Skrabanek 1994). 
6.0 Conclusion and implications 
CVD is a complex group of diseases highly relevant on the public health agenda. Many risk 
factors of CVD have been identified and total risk scores developed, which makes it possible to 
assess risk in individuals free of CVD. Ethnic inequalities in risk of CVD have been revealed and 
shown to exist in the Norwegian society. Both intermediate and primary risk factors, including 
those of behaviour, were unequally distributed among the eleven ethnic groups in this study. 
Factors contributing to the development of atherosclerosis and CVD are many, and they may be 
found in the surrounding environment as well as in the individual. Even though this study cannot 
actually explain the causes of ethnic differences in cardiovascular health, suggestions have been 
discussed and laid out. Following a holistic and social understand of health and its determinants, 
possible causes may be found in all the layers of the rainbow.  
Although there are differences in genetic susceptibility, it seems most likely that the causes for 
ethnic differences in cardiovascular health are imposed and maintained by structural and social 
contexts; thereby being both avoidable and inequitable. Knowing that the number of immigrants 
in Norway will increase; attention towards ethnicity and health from public health policy makers 
is required. In accordance with the rainbow of determinants, it is necessary to act on several 
levels, in order to succeed in preventing CVDs in all the ethnic groups. The example from an 
intervention study in Romsås suggests that low-cost preventions efforts can be successful when 
taking a holistic approach. There is a call for more research in order to understand the ethnic 
differences in cardiovascular health, and prevent it from becoming black box epidemiology.  
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Abstract 
Background Risk of cardiovascular disease (CVD) varies between ethnic groups. The aim of 
this study was to investigate differences in cardiovascular risk factors and total cardiovascular 
risk using NORRISK and Framingham equations, between ethnic groups in Norway.  
Design A cross-sectional study using data from the Cohort of Norway (CONOR). 
Methods A sample of 62 145 participants, 40-65 years of age, originating from 11 different 
geographical regions including Norway, were examined. Self-reported variables, blood samples 
and physical measurements were used to estimate age-adjusted mean levels of CVD risk factors. 
10-year risk of CVD events were calculated for 60 015 participants using an updated version of 
the Framingham risk equation. NORRISK was used to calculate 10-year risk of cardiovascular 
mortality in 54 027 of the participants. 
Results Differences in risk factors and in Framingham risk scores were observed in both men 
and women. NORRISK showed differences in men only. Immigrants from the Indian 
subcontinent had the highest levels of blood glucose, waist hip ratio (WHR), triglycerides, the 
lowest high density lipoprotein (HDL) levels, and the highest prevalence of diabetes. Immigrants 
from Former Yugoslavia had the highest Framingham risk scores and the highest total 
cholesterol/HDL ratio, high levels of blood pressure, overweight measures and smoking. Lower 
risk levels were particularly observed in immigrants from East Asia. Most of the groups reported 
high levels of inactivity and smoking. 
Conclusion Previously reported excess risk of diabetes and other risk factors of CVD in 
immigrants from the Indian subcontinent were supported in this study. We also showed that 
immigrants from Former Yugoslavian countries have a higher total 10-year risk of CVD events 
than other ethnic groups. CVDs are preventable diseases, and this study adds new information 
about ethnic groups in Norway which need to be addressed with further research and primary 
prevention efforts. 
Keywords cardiovascular diseases, risk factors, ethnic groups, lipids, NORRISK, Framingham  
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Introduction  
Cardiovascular disease (CVD) is the leading cause of death worldwide, a major cause of 
disability and at the same time highly preventable (WHO 2007). Affecting both rich and poor 
countries, CVD is increasing in developing countries carrying the heaviest load of more than 80 
per cent of global deaths (Yusuf, S. et al. 2001). Improvements in prevention, better diagnostics 
and treatment in many developed countries have resulted in an opposite trend (Yusuf, S. et al. 
2001).  Norway is an example having experienced a significant decline in cardiovascular 
mortality the past twenty years (Statistics Norway 2010). Still CVD persists as the national 
leading cause of death, emphasizing the importance of focusing on prevention. Asymptomatic 
patients with high risk need to be identified in order to offer primary prevention to those most 
likely to benefit from it (Norheim et al. 2009).  
A growing amount of evidence indicates unequal distribution of CVD events and CVD risk 
factors based on ethnicity (Chaturvedi 2003; Forouhi & Sattar 2006; Kurian & Cardarelli 2007). 
In particular, immigrants from South Asia (the Indian Subcontinent) have repeatedly been found 
to have increased risk of ischaemic heart disease (IHD) (Lee et al. 2001; McKeigue et al. 1989; 
Wild & Mckeigue 1997), higher prevalence of insulin resistance and several other metabolic 
disturbances (Chambers et al. 2001; Mather & Keen 1985; Tillin et al. 2005).  People of African 
descents have been reported to have increased risk of hypertension and stroke when compared to 
Europeans (Balarajan 1991; Chaturvedi et al. 1993). Despite several studies revealing such 
disparities, a lack of data on this topic implies a demand for more research (Ranganathan & 
Bhopal 2006). This need is especially pressing in other European countries than the UK, where 
most existing studies have been carried out (Bhopal 2000). 
Two previous studies in Norway documented differences in CVD risk among immigrants living 
in Oslo. Individuals originating from five countries in Asia and the Middle East, in addition to 
people born in Norway were compared in both studies (Glenday et al. 2006; Kumar et al. 2009). 
No study has explored ethnic differences in risk of CVD among other immigrant groups in 
Norway, nor studied immigrants living outside of Oslo in this respect. Using data from a large 
Norwegian cohort, this study’s main objective was to investigate variations in risk factors for and 
total risk of CVD among eleven ethnic groups. Total risk of CVD was calculated using 
NORRISK and Framingham risk score models. 
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Materials and Methods 
Cohort of Norway (CONOR) 
This is a cross sectional study, using data from the Cohort of Norway (CONOR); a database 
made up of ten different Norwegian health surveys. The surveys were carried out during the time 
period 1994-2003. A total number of 174 430 individuals participated in at least one CONOR-
survey; some of them participated in one or two more. Overall participation rate is 58 %. Details 
on each of the surveys have been reported elsewhere (Næss et al. 2008). CONOR was 
established through collaboration between the Norwegian Institute of Public Health (NIPH) and 
the epidemiological centers at the University of Tromsø, The Norwegian University of Science 
and Technology in Trondheim, the University of Bergen and the University of Oslo (Aamodt et 
al. 2010; Næss et al. 2008).  
In all the surveys, invited persons were asked to fill in a questionnaire covering variables such as 
smoking habits, drug use, and health condition. Included variables from the CONOR 
questionnaire are self-reported diseases such as diabetes, myocardial infarction (MI) and angina 
pectoris. Other questions revealing smoking habits, physical activity, time since last meal, use of 
blood pressure and lipid lowering medication have also been included. Physical inactivity was 
defined as reporting less than 1 hour of both light (no sweating or out of breath) and hard 
(sweating or out of breath) physical activity when the respondents were asked to estimate an 
average of activity in a typical week during the previous year. Places of birth act as indicators of 
ethnicity which is understood as a concept including biologic, social and cultural aspects (Bhopal 
2004). In the available dataset for our study, countries of birth were merged into 16 larger birth 
regions; Table 1 shows which countries that belong to each region. Information about the 
number of participants from each country represented in each region, are thus not obtainable in 
the current study.  
Moreover, a simple clinical examination was performed. Body weight (kilograms) and height 
(centimeters) were measured manually until the year of 2000, after that an electronic height and 
weight scale was applied. All participants wore light clothing without shoes for these 
measurements. Body mass index (BMI) was calculated as body weight (in kilograms) divided by 
the square of height (in metres). Waist and hip circumference were measured with a tape of steel 
placed horizontally while the participants were standing and breathing normally. The waist to hip 
ratio (WHR) was calculated based on these measurements. Blood pressure was measured in 
mmHg using an automatic instrument (DINAMAP, Criticon, Tampa, FL, USA). The participants 
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rested for two minutes followed by three blood pressure measurements with one-minute 
intervals. The last two measurements were used to calculate mean systolic blood pressure which 
were applied in our analyses.  
At the clinical examination, a non-fasting venous blood sample was drawn. Total cholesterol 
(mmol/L), high density lipoprotein (HDL) cholesterol (mmol/L), glucose (mmol/L) and 
triglycerides (mmol/L) were measured directly using an enzymatic method (Boehringer 148393, 
Boehringer-Mannheim, Federal Republic of Germany –from 2000 Hitachi 917 auto analyzer, 
Roche Diagnostics, Switzerland). The analyses were performed by the Department of Clinical 
Chemistry, Ullevål University Hospital, in Oslo; the Department of Clinical Chemistry, 
Levanger Hospital; and the Department of Clinical Chemistry, University Hospital North-
Norway, Tromsø. In connection to these surveys, calibration procedures between the laboratories 
were carried out (Næss et al. 2008). 
 
Study sample  
The sample was restricted to the first time the individuals participated in a CONOR-survey. A 
number of 38 066 individuals missed information on birth place and were consequently 
excluded. Regions with few representatives (the Pacific Ocean (n=8), Central America (n=55), 
Oceania/Pacific (n=31), Central Asia (n=13) and one unspecified group (n=1) were excluded. 
Western Europe (n=3329) was left out because the region was considered as relatively similar to 
Norway and it was a preference to maintain the perspective having fewer regions in the analyses.  
After exclusions, the total number of participants was 132 927, originating from eleven different 
geographical regions. 
Further exclusion was based on risk factors included in the risk score calculations. The sample 
was limited to participants in the age range 40-65 years old (n= 63 186 excluded) since this is the 
age group relevant for the NORRISK algorithm (Selmer et al. 2008) and within the age range of 
the Framingham sample(D'Agostino et al. 2008). Participants with missing triglyceride levels 
(n=94), triglyceride levels < 0, 2 mmol/L or triglyceride levels > 20 mmol/L (n=11) were 
excluded. One extreme total cholesterol value (48 mmol/L), missing blood pressure values 
(n=58) and missing HDL cholesterol values (n=17) were all further excluded giving the sample 
plausible values of the risk factors. Participants missing information on self-reported diabetes 
(n=948), use of blood pressure medication (n=482) and smoking status (5984) were also 
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excluded. One person who answered both yes and no on the question about daily smoking was 
excluded, giving a total sample of 62 145 participants.  
From the main sample further exclusions resulted in two slightly different sample sizes 
according to the risk equations. Both Framingham and NORRISK are restricted to asymptomatic 
subjects consequently excluding people with history of MI, angina pectoris or stroke giving a 
sample of 60 015 individuals for the calculation of Framingham 10 year risk of CVD.  For 
NORRISK people with diabetes, people who reported either current or previous use of 
antihypertensive and/or lipid-lowering treatment were also excluded.  According to the European 
Guidelines on CVD prevention they were already declared to be in high risk (Graham et al. 
2007). Thus, the total number of people in the NORRISK sample was 54 027. 
 
Definition of risk factors 
Hypertension was defined in individuals currently using blood pressure treatment and those 
having a systolic blood pressure ≥ 140 mmHg in accordance with the definitions of the World 
Health Organization (WHO) and International Society of Hypertension (Whitworth 2003). High 
total cholesterol was defined according to the European Society of Cardiology (ESC) Guidelines 
(Graham et al. 2007) recommending a total cholesterol level of less than 5 mmol/L although this 
is a relatively low threshold.  Low HDL cholesterol levels were defined following the same 
guidelines suggesting low levels to be < 1 mmol/L in men and < 1.2 mmol/L in women.  A high 
cholesterol/HDL ratio was defined as > 4. High WHR was defined as 1.0 or greater in men, and 
0.85 or greater in women (WHO 2000) and high BMI as ≥25 using the WHO criteria (WHO 
1995).  
 
Statistical analyses and risk score calculation 
Data were analysed using the PASW version 18. The different variables were reported as 
fractions for categorical variables and mean values including either standard deviation or 95% 
confidence intervals for continuous variables. Age-adjustment was performed by linear 
regression, and done separately for each single risk factor, calculated risk scores (calculation 
described below) and the prevalence estimates. Triglycerides and glucose were additionally 
adjusted for time since last meal. Differences in risk factors and calculated total risk between the 
ethnic groups were assessed using one-way analyses of variance.  Post hoc tests with Norway as 
reference group were performed to study differences between total risk scores when overall 
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variance was found significant. All analyses were stratified by sex.  P-values less than 0, 05 were 
considered statistically significant. 
We calculated 10-year risk of general CVD events for each individual using a recent version of 
the Framingham risk equation based on age, gender, total cholesterol, HDL cholesterol, treated 
and untreated systolic blood pressure, smoking (yes/no) and diabetes (yes/no) (D'Agostino et al. 
2008). The Framingham equation was derived based on a Caucasian American population free of 
CVD and in the age range 30-74 years old(Anderson et al. 1991). General CVD includes both 
fatal and non-fatal events such as coronary death, MI, coronary insufficiency, angina, ischaemic 
stroke, hemorrhagic stroke and transient ischaemic attack, peripheral artery disease and heart 
failure. Chosen threshold for dividing participants into the categories high or low risk was 10 %, 
although such thresholds can be defined differently depending on the acceptance of risk 
(Fretheim et al. 2002; Greenland et al. 2010) 
10-year risk of CVD mortality was calculated using NORRISK, the Norwegian version of the 
European SCORE (Systematic COronary Risk Evaluation) algorithm (Selmer et al. 2008). 
NORRISK is recently calibrated to national mortality figures as recommended in the European 
guidelines (Graham et al. 2007) since SCORE was found to overestimate risk in the Norwegian 
population (Lindman et al. 2006; Lindman et al. 2007). NORRISK calculates total risk based on 
age, gender, systolic blood pressure, total cholesterol and smoking (yes/no) (Selmer et al. 2008). 
Defined thresholds for high risk using NORRISK differ according to age. People aged 40-49 
years are recommended to have less than 1 % risk, people aged 50-59 are recommended less than 
5 %, while people aged 60-69 should have less than 10 % total risk  (Norheim et al. 2009). We 
chose, however, to have a cut-off of 5 % when dividing people into high/low risk in order to 
make comparing of ethnic groups more manageable.  Also, the prevalence of people with high 
risk was estimated adjusted to the age of 47,7 years in men and 47,6 years in women - neither far 
from the age of 50 making the chosen cut-off more justifiable. 5 % is also the limit used for 
SCORE in the ESC Guidelines (Graham et al. 2007). 
 
Ethics 
All the participants gave their written informed consent (Næss et al. 2008) and the project is 
approved by the CONOR Steering Committee. 
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Results  
The study included 32 684 women and 29 461 men aged 40-65 years from eleven different birth 
regions, representing 4 continents. In Table 2-4 we show summary statistics for main variables 
for the different ethnic groups.   
We found significant differences in systolic blood pressure, serum glucose, WHR and BMI 
between ethnic groups (Table 2) (p <0,001 for overall equality). Men born in Norway and 
Former Yugoslavia had the highest mean values of systolic blood pressure, while among women 
the highest blood pressure was found in Sub-Saharan Africans. People from the Indian 
subcontinent had the highest levels of glucose and WHR, whereas North American immigrant 
women had the lowest levels of glucose and WHR.  Both Former Yugoslavians and people from 
the Indian subcontinent showed relatively high levels of BMI, though not the highest. 
Furthermore, significant differences in total cholesterol, HDL cholesterol, total cholesterol/HDL 
cholesterol ratio and triglycerides were observed (Table 3) (p < 0,001 of overall equality).  Men 
and women from East Asia had the lowest mean of total cholesterol. Participants from the Indian 
subcontinent had the lowest adverse levels of HDL cholesterol along with men from Former 
Yugoslavia and North Africa. HDL cholesterol was naturally lower in men than in women. East 
Asian women had the lowest total cholesterol/HDL ratio while the highest was seen in Former 
Yugoslavians, both men and women. East Asia and North America was among the regions with 
lower levels of triglycerides and people from the Indian subcontinent had the highest triglyceride 
levels. 
Years of education, prevalence of diabetes, smoking, inactivity, previous MI and angina, use of 
blood pressure and lipid lowering medication varied significantly between ethnic groups (Table 
4) (p <0,001 for overall equality). Reported history of stroke, however, did not differ 
significantly in men or women (p=0,212 and p=0,074 respectively). Highest prevalence of 
diabetes was found among the group from the Indian subcontinent. There were large differences 
in smoking prevalence according to gender; generally more men than women smoked. In some 
groups this trend was especially evident such as among North Africans. European women 
seemed most inclined to smoking. Inactivity was relatively common, especially for participants 
from the Asian and African regions as well as Former Yugoslavia. In each ethnic group the 
prevalence of previous CVD events (MI, angina or stroke) was less than ten percent. Men from 
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the Indian subcontinent and North Africa both had the highest prevalence of MI in the male part 
of the population.  
In Figure 1 we show the prevalence of people with high values of some of the risk factors. These 
include total cholesterol/HDL ratio, total cholesterol, blood pressure, WHR and BMI. All 
differed significantly between ethnic groups (p < 0,001 for overall equality and p=0,031 for 
hypertension in women,). The highest prevalence of hypertension corresponded with the highest 
values of mean systolic blood pressure, but additionally revealed high prevalence of 
hypertension among people from the Indian subcontinent. Prevalence of high WHR was also 
highest in men and women from this region corresponding with the highest mean values (Fig.1.). 
Lower prevalence of overweight measures corresponded with low mean values of WHR and 
BMI in East Asians. 
 
Framingham 
In Table 5 we show calculated 10-year risk of general CVD based on the Framingham equation 
for the different ethnic groups. Statistical differences were observed in both sexes, and men 
scored generally higher than women (p<0, 01 for overall equality). Immigrants from Former 
Yugoslavian countries had the highest mean scores (men and women) although not statistically 
different.  No ethnic group had significantly higher scores than Norwegians. Immigrants from 
the Indian subcontinent had the third highest risk scores in both sexes. When examining the 
proportions of people defined in high risk of general CVD (Fig.2.a.), some regions showed 
slightly higher percentages than men from Former Yugoslavia. Several birth regions had 
significantly lower risk scores compared to people born in Norway. East Asians had the lowest 
predicted risk scores (men and women) along with women from South East Asia, with the lowest 
score among women (p<0, 05, compared to Norway). 
 
NORRISK 
Based on calculated risk of CVD mortality using NORRISK, the mean risk values between the 
ethnic groups only differed significantly in the male part of the population (Table 6) (p<0,001 for 
overall equality). Here, three regions; the Middle East, South East Asia and North Africa, 
differed significantly from Norway having lower scores (p<0,001, p=0,001 and p=0,043, 
 47 
 
respectively). North American men had the highest score and North African men the lowest, but 
these two did not differ significantly from each other (confidence intervals not overlapping). We 
did not observe any differences among women, but the confidence intervals for Norwegian and 
Middle East women did not overlap.   
 
Discussion  
The results in this cross sectional study revealed significant variations in risk of CVD among 
ethnic groups living in Norway. We observed significant differences in almost all the variables. 
Differences in total risk were identified between Norway and other birth regions. Ethnic groups 
with markedly higher levels of risk factors and total risk were in particular the Indian 
subcontinent and Former Yugoslavia showing tendencies evident in both sexes.  
In general, risk scores were higher using the Framingham equation than NORRISK. This was 
expected since Framingham has a wider range of predicted outcomes than NORRISK. The 
equation also includes additional risk factors compared to NORRISK, which also had a different 
sample than Framingham, excluding people in risk with diabetes and those being treated for 
hypertension and hyperlipidemia. This had an attenuating effect on the scores making it more 
difficult to get a clear picture of ethnic differences when using NORRISK.  
Some countries of the East Asian region (Japan and China) have previously been found to have 
lower risk of CVD (Menotti et al. 1993; Yusuf, Salim et al. 2001). This concur with our results 
showing comparative lower levels of overweight and lipids, further reflected in lower calculated 
risk according to the Framingham equation. 
North America, despite its known increasing epidemic of obesity, especially in the United States 
(U.S.) (Mokdad et al. 2001), was comparably low in total cholesterol/HDL ratio, triglycerides, 
diabetes and WHR and BMI. Possible explanations for their favorable levels might be the 
inclusion of Canada since Canadians in general have not yet reached the same levels in 
overweight as their U.S. neighbors (Katzmarzyk & Mason 2006). An additional explanation is  
“the healthy migrant effect”, suggesting that these immigrants constitute a selectively healthy 
group from their countries of origin (Fennelly 2007; Lu 2008).  North Americans in our study 
represent a highly educated part of their countries. North American immigrants had the highest 
mean value in years of education, which is an important social determinant of health in North 
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American countries (Braveman et al. 2011; Choiniere et al. 2000). However, men from North 
America had the highest mean score in 10-year risk of CVD mortality. 
People of African descent have been reported to have higher values of blood pressure than other 
ethnic groups (Chaturvedi et al. 1993), which was confirmed in the female part of this study 
sample.  
Previous findings from both national (Glenday et al. 2006; Kumar et al. 2009) and international 
studies (Chambers et al. 2001; Hayes et al. 2002; Kain & Catto 2002; Mather & Keen 1985; 
McKeigue et al. 1988; Tillin et al. 2005) are in accordance with our findings suggesting a higher 
risk of insulin resistance and other metabolic risk factors in immigrants from the Indian 
subcontinent. This group had high scores in total risk of general CVD, high prevalence of 
diabetes and inactivity, elevated mean levels of blood glucose, general overweight (BMI) 
(especially in women), abdominal fat (WHR), triglycerides and a high total cholesterol/HDL 
ratio due to low HDL cholesterol levels. People from the Indian subcontinent have also been 
reported to have increased risk of IHD  based on mortality numbers in the UK (Balarajan 1991; 
Wild & Mckeigue 1997). Such statements cannot be made here, but our findings indicate general 
accordance. Men from the Indian Subcontinent had among the highest prevalence of MI, 
although the prevalence was generally low in all groups. Previous studies (McKeigue 1992; 
McKeigue et al. 1988) have not been able to explain the excess risk of CHD in people from the 
Indian subcontinent as caused by smoking or hypertension. Relatively low smoking prevalence 
and intermediate mean values of systolic blood pressure in this study support this. However, an 
examination of proportions with hypertension shows high prevalence in the Indian subcontinent 
relative to other groups.  In search for explanations of the excess risk in this group, researchers 
have also directed attention to people who have not migrated, but still live in the Indian 
subcontinent. Studies comparing immigrants in the UK with their counterparts in India suggest 
that migration to higher income countries might result in an increased risk of CVD (Patel et al. 
1995; Patel et al. 2006). The prevalence of diabetes is also 2-3 fold higher in the Indian 
subcontinent than reported in Western countries (Jafar 2006). A hypothesis called the “thrifty 
phenotype hypothesis” has been proposed based on observations where small birth weight and 
maternal malnutrition is associated with increased risk of chronic diseases in later life (Hales & 
Barker 2001). This might serve as an explanation for high levels of CVD risk factors among 
immigrants from the Indian subcontinent, emphasizing environmental influences in early life as 
part of the pathogenesis (Stein et al. 1996; Yajnik 2001). In countries of the Indian subcontinent 
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as in other developing countries undergoing epidemiologic transition, the prevalence of diabetes 
is also increasing as a consequence of urbanization, correspondingly finding higher prevalence of 
diabetes in urban areas than in rural areas (Goyal & Yusuf 2006; Mohan 2004; Singh et al. 
1997).   
To our knowledge, no previous study has examined the risk of CVD in Former Yugoslavian 
immigrants in Norway. However, a study from Switzerland (Grossmann et al. 2010) found 
Former Yugoslavian immigrants more likely to be overweight than the Swiss native born. This is 
supported in our study where both men and women from Former Yugoslavia had significantly 
higher levels of overweight measures than several other groups (according to the 95 % CI) and 
ranked high in prevalence of both general overweight and abdominal fat. This could be due to 
nutrition since people from Former Yugoslavia are known to have a rich diet with high use of 
cooking oil, and prevalence of overweight was also reported as high even before the Balkan war 
(Kruseman et al. 2003). Participants from former Yugoslavia had the highest calculated 10-year 
risks of CVD according to the Framingham equation particularly reflected in their elevated total 
cholesterol/HDL ratio. The fact that Former Yugoslavians ranked highest in this score 
exemplifies the importance of estimating total risk when assessing ethnic differences, since this 
group also showed intermediate levels in some risk factors. This group did not score higher than 
Norwegians significantly, probably a consequence of small groups sizes in this region compared 
to Norway and that Norwegians also had high scores.  Reason for migration of the immigrants in 
this study is not known, nevertheless, immigrants from Former Yugoslavian countries might 
represent post war-refugees struggling with post-war effects. This has been reported among 
Former Yugoslavian immigrants in other countries (Markovic et al. 2002; van den Heuvel 1998). 
Post-traumatic stress disorder is one of the possible consequences associated with CVD 
(Boscarino & Chang 1999; Kibler et al. 2009) 
This study has several strengths such as the possibility of comparing different ethnic groups 
living in both rural and urban parts of Norway. Secondly, we have a large sample size resulting 
in comparable subgroups, although the statistical strength was still somewhat limited due to 
group sizes after exclusion.  
Limitations include heterogeneity due to the application of large birth regions as indicators of 
ethnic belonging. South Asians is known to be a heterogeneous group regarding CVD risk 
factors (Bhopal et al. 1999) which might as well apply for the other regions. This demands 
cautious interpretation of the findings. It is also noted that the national studies mentioned cannot 
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be referred to as entirely different studies since present study might include duplicate participant 
data. About 1151 participants from our CONOR sample participated in the Oslo Immigrant 
Health study which was used in the Norwegian studies mentioned earlier. Another limitation is 
the relatively low participation rate which increases the risk of selection bias. 
 
Conclusion 
This study adds information on CVD risk factors among immigrant groups living in Norway that 
has not been documented previously. Immigrants from Former Yugoslavia and the Indian 
subcontinent show higher risk in both sexes, reflected both in single risk factors and total risk 
scores. Culturally adapted lifestyle interventions would be recommended for most of the groups 
since many reported unhealthy lifestyles. Although this study cannot explain the differences 
between ethnic groups to the fully or the etiology of such, it might function as a first step 
towards a better understanding. More research is needed in order to improve the adaption of 
primary prevention efforts according to the different ethnic groups in Norway.  Examining risk 
in smaller ethnic groups within our large regions would be of particular interest, before possible 
explanations for the inequalities can be examined, identified and further addressed.  
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Tables and figures 
Table 1:  An overview of the countries included in each birth region.   
Birth region: Countries: 
Eastern Europe, n=220 
( 72 % women) 
Bulgaria, Estonia, Belarus, Latvia, Poland, Romania, the Soviet-Union, Lithuania, 
Moldova, Russia, Czechoslovakia, the Ukraine, DDR (code no longer in use), Hungary, 
Slovakia, the Czech Republic  
 
Former Yugoslavia, n=179  
(47 % women) 
Albania, Croatia, Yugoslavia, Slovenia, Bosnia-Herzegovina, Macedonia  
North Africa, n=71 
(40,8 % women) 
Algeria, Egypt, Libya, Morocco, Sudan, Tunisia 
Sub-Saharan-Africa, n=183 
(39 % women) 
 
Angola, Botswana, Equatorial-Guinea, the Ivory Coast/Côte d'Ivoire, Eritrea, Ethiopia, 
Dijbouti, Gambia, Ghana, Guinea, Guinea-Bissau, Cameroon, Cape Verde, Kenya, 
Congo, Zaire, Liberia, Madagascar, Mauretania, Mauritius, Namibia, Nigeria, 
Mozambique, Zimbabwe, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, 
Tanzania, Togo, Uganda, Zambia 
 
Middle East, n=669 
(40 % women) 
Turkey, Armenia, Azerbaijan, Iraq, Iran, Jordan, Kuwait, Lebanon, Saudi Arabia, Syria, 
Yemen 
 
Indian Subcontinent, n=1071 
(41 % women) 
Bangladesh, Myanmar (Burma), Sri Lanka, India, Nepal, Pakistan 
East Asia, n=104 
(58 % women) 
Taiwan, Hong Kong, Japan, China, North Korea, South Korea 
North America, n=180 
(60 % women) 
Canada, USA 
South America, n=159 
(55 % women) 
Argentina, Bolivia, Brazil, Guyana, Chile, Colombia, Ecuador, Paraguay, Peru, 
Suriname, Uruguay, Venezuela 
South-East Asia, n=611 
(63 % women) 
The Philippines, Indonesia, Kampuchea, Laos, Malaysia, Singapore, Thailand, Vietnam  
n, number of participants in the main sample of a total of 62 145 participants. 
 
 
 
 
 
 
 
 
 
 
 
 56 
 
Table 2: Characteristics of 62 145 participants, mean values (95 % CI), adjusted for age. Data from 
Cohort of Norway, 1994-2003. 
SD, standard deviation; CI, confidence interval; WHR, waist hip ratio; BMI, body mass index.    aAdjusted for time since last meal. All 
variables had P-values < 0,001 for overall equality.  
 
 
 
 
 
      N Age, years 
(SD) 
Systolic blood pressure, 
mmHg 
Serum glucose
a
, 
mmol/L 
WHR BMI 
MEN           
Norway 27 699 48,6 (6,9) 135,0 (134,8-135,1) 5,46 (5,44-5,48) 0,908 (0,907-0,909) 26,5 (26,5-26,6) 
Eastern 
Europe 
62 51,1 (8,2) 131,7 (127,8-135,5) 5,34 (4,97-5,72) 0,912 (0,897-0,927) 26,7 (25,8-27,6) 
Former 
Yugoslavia 
94 45,5 (6,2) 132,8 (129,7-136,0) 5,72 (5,42-6,02) 0,920 (0,908-0,933) 27,8 (27,1-28,5) 
North Africa 42 47,1 (7,6) 121,7 (117,0-126,4) 6,11 (5,66-6,57) 0,912 (0,894-0,930) 26,8 (25,8-27,9) 
Sub-Saharan 
Africa 
112 45,2 (5,7) 131,5 (128,7-134,4) 5,42 (5,14-5,70) 0,887 (0,875-0,898) 25,6 (24,9-26,2) 
Middle East 403 46,1 (5,9) 126,8 (125,2-128,3) 5,81 (5,67-5,96) 0,912 (0,906-0,918) 27,1 (26,8-27,5) 
Indian 
subcontinent 
635 46,7 (6,3) 129,7 (128,5-130,9) 6,42 (6,31-6,54) 0,947 (0,942-0,951) 26,7 (26,5-27,0) 
East Asia 44 47,8 (7,1) 126,0 (121,4-130,6) 5,84 (5,40-6,28) 0,889 (0,871-0,907) 23,8 (22,8-24,8) 
North America 72 47,4 (7,0) 131,3 (127,7-134,9) 5,51 (5,16-5,86) 0,909 (0,894-0,923) 26,4 (25,6-27,2) 
South America 72 45,2 (4,6) 127,3 (123,7-130,9) 5,58 (5,50-6,20) 0,928 (0,914-0,942) 27,9 (27,1-28,7) 
South-East 
Asia 
226 47,1 (6,0) 127,0 (124,9-129,0) 5,9 (5,71-6,10) 0,884 (0,876-0,891) 24,4 (23,9-24,9) 
WOMEN           
Norway 30 999 48,4 (6,9) 128,5 (128,3-128,7) 5,24 (5,23-5,26) 0,797 (0,797-0,798) 25,6 (25,5-25,6) 
Eastern 
Europe 
158 46,8 (6,6) 124,9 (122,2-127,5) 5,23 (5,03-5,43) 0,780 (0,769-0,790) 25,6 (24,9-26,2) 
Former 
Yugoslavia 
85 46,1 (6,3) 128,4 (124,8-132,0) 5,79 (5,53-6,05) 0,806 (0,793-0,820) 28,5 (27,6-29,5) 
North Africa 29 44,9 (5,1) 123,8 (117,6-130,0) 5,72 (5,28-6,16) 0,850 (0,826-0,873) 30,7 (29,1-32,3) 
Sub-Saharan 
Africa 
71 44,5 (4,6) 131,0 (127,0-134,9) 5,82 (5,53-6,10) 0,814 (0,798-0,829) 28,4 (27,4-29,4) 
Middle East 266 46,6 (5,9) 122,6 (120,6-124,7) 5,84 (5,69-5,99) 0,825 (0,817-0,833) 29,2 (28,6-29,7) 
Indian 
subcontinent 
436 46,7 (5,9) 126,3 (124,7-127,9) 6,11 (6,00-6,23) 0,864 (0,858-0,870) 28,8 (28,4-29,2) 
East Asia 60 46,9 (7,4) 122,2 (117,9-126,5) 5,97 (5,66-6,29) 0,786 (0,769-0,802) 23,5 (22,3-24,6) 
North America 108 45,8 (5,6) 125,5 (122,3-128,7) 5,08 (4,84-5,31) 0,773 (0,761-0,786) 25,6 (24,8-26,4) 
South America 87 45,0 (4,9) 120,9 (117,3-124,4) 5,30 (5,04-5,56) 0,819 (0,805-0,833) 26,6 (25,7-27,5) 
South-East 
Asia 
385 46,6 (5,6) 126,0 (124,3-127,7) 5,61 (5,48-5,73) 0,811 (0,804-0,817) 24,3 (23,9-24,7) 
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Table 3: Blood lipids, mean values mmol/L  for 62 145 participants (95 % CI), adjusted for age. Data from 
Cohort of Norway, 1994-2003. 
 N Total cholesterol HDL cholesterol Total cholesterol/HDL ratio Triglyceridesa 
MEN          
Norway 27 699 5,95 (5,94-5,95) 1,24 (1,24-1,25) 5,11 (5,09-5,13) 2,03 (2,01-2,04) 
Eastern Europe 62 5,65 (5,38-5,92) 1,23 (1,15-1,32) 4,94 (4,54-5,34) 2,27 (1,94-2,60) 
Former Yugoslavia 94 5,59 (5,37-5,80) 1,08 (1,02-1,15) 5,46 (5,14-5,79) 2,32 (2,06-2,59) 
North Africa 42 5,34 (5,01-5,66) 1,09 (0,99-1,19) 5,14 (4,65-5,62) 2,08 (1,68-2,48) 
Sub-Saharan Africa 112 5,42 (5,22-5,62) 1,37 (1,30-1,43) 4,19 (3,89-4,49) 1,65 (1,40-1,90) 
Middle-East 403 5,51 (5,41-5,62) 1,13 (1,10-1,17) 5,16 (5,00-5,32) 2,38 (2,25-2,50) 
Indian 
subcontinent 
635 5,60 (5,52-5,68) 1,08 (1,05-1,11) 5,45 (5,33-5,58) 2,69 (2,59-2,80) 
East Asia 44 5,34 (5,02-5,66) 1,33 (1,23-1,43) 4,25 (3,78-4,73) 1,84 (1,45-2,23) 
North America 72 5,83 (5,59-6,08) 1,32 (1,24-1,40) 4,85 (4,48-5,22) 1,78 (1,47-2,08) 
South America 72 5,81 (5,56-6,05) 1,15 (1,07-1,22) 5,28 (4,91-5,65) 2,31 (2,00-2,61) 
South-East Asia 226 5,63 (5,49-5,77) 1,23 (1,18-1,27) 4,82 (4,61-5,03) 2,62 (2,45-2,79) 
WOMEN          
Norway 30 999 5,82 (5,81-5,83) 1,52 (1,51-1,52) 4,08 (4,07-4,10) 1,43 (1,42-1,44) 
Eastern Europe 158 5,56 (5,39-5,72) 1,62 (1,56-1,68) 3,66 (3,45-3,88) 1,36 (1,22-1,50) 
Former Yugoslavia 85 5,86 (5,64-6,09) 1,38 (1,29-1,46) 4,55 (4,26-4,85) 1,87 (1,68-2,06) 
North Africa 29 5,49 (5,10-5,87) 1,32 (1,18-1,47) 4,27 (3,77-4,77) 1,61 (1,28-1,94) 
Sub-Saharan Africa 71 5,50 (5,25-5,74) 1,57 (1,48-1,67) 3,62 (3,30-3,94) 1,28 (1,07-1,49) 
Middle East 266 5,36 (5,24-5,49) 1,35 (1,31-1,40) 4,14 (3,97-4,30) 1,75 (1,64-1,86) 
Indian 
subcontinent 
436 5,41 (5,31-5,51) 1,26 (1,23-1,30) 4,49 (4,36-4,62) 2,11 (2,03-2,20) 
East Asia 60 5,18 (4,91-5,44) 1,59 (1,49-1,69) 3,44 (3,09-3,79) 1,33 (1,10-1,56) 
North America 108 5,44 (5,24-5,64) 1,57 (1,49-1,64) 3,68 (3,42-3,94) 1,34 (1,17-1,51) 
South America 87 5,68 (5,46-5,90) 1,42 (1,34-1,51) 4,18 (3,89-4,47) 1,59 (1,40-1,78) 
South-East Asia 385 5,52 (5,42-5,63) 1,49 (1,45-1,53) 3,92 (3,78-4,06) 1,67 (1,58-1,76) 
CI, confidence interval; HDL, high density lipoprotein.     aAdjusted for time since last meal. All variables had P-values < 0,001 for 
overall equality.  
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Table 4: Prevalence (%) and estimated mean of self-reported variables in 62 145 participants, 
adjusted for age. Data from Cohort of Norway, 1994-2003. 
  N Diabetes Daily 
smoking 
Being 
inactive  
History 
of MI 
History 
of 
angina 
pectoris 
History 
of 
stroke 
Using  BP  
medicine 
Using 
lipid 
medicine 
Years of 
education 
(SD) 
MEN 
 
          
Norway 27 699 2 35 19 2 3 1 8 7 12,1 (3,33) 
Eastern 
Europe 
62 3 44 17 5 9 0 6 8 14,9 (3,39) 
Former 
Yugoslavia 
94 3 45 36 2 4 0 13 10 12,5 (3,39) 
North Africa 42 10 55 38 6 8 5 13 10 11,6 (3,37) 
Sub-Saharan 
Africa 
112 4 32 30 3 8 0 9 7 14,6 (3,39) 
Middle East 403 6 56 35 5 8 1 10 11 12,7 (3,41) 
Indian 
subcontinent 
635 14 28 44 6 8 2 15 13 12,3 (3,53) 
East Asia 44 5 43 50 3 7 2 14 6 12,3 (3,65) 
North 
America 
72 3 29 20 0 3 0 6 4 16,1 (3,31) 
South 
America 
72 5 48 33 1 1 2 7 6 13,2 (3,31) 
South-East 
Asia 
226 7 56 44 4 7 1 12 8 11,3 (3,46) 
WOMEN    
 
             
Norway 30 999 1 39 15 1 1 1 7 5 11,8 (3,52) 
Eastern-
Europe 
158 3 35 21 1 4 1 8 2 14,6 (3,27) 
Former 
Yugoslavia 
85 4 38 39 4 4 4 10 8 10,6 (3,32) 
North Africa 29 7 2 38 0 1 0 20 13 7,5 (3,55) 
Sub-Saharan 
Africa 
71 5 5 42 0 1 2 10 3 11,9 (3,62) 
Middle East 266 8 25 41 0 4 1 14 9 10,2 (3,26) 
Indian 
subcontinent 
436 14 2 42 1 3 2 15 11 10,1 (3,34) 
East Asia 60 4 21 39 0 4 0 11 6 12,7 (3,41) 
North 
America 
108 2 27 16 1 1 1 5 6 15,3 (3,22) 
South 
America 
87 3 28 24 0 3 1 8 8 12,9 (3,26) 
South-East 
Asia 
385 5 5 39 3 5 1 10 3 10,6 (3,34) 
SD, standard deviation; MI, myocardial infarction; BP, blood pressure. All variables had P-values  < 0,001 for overall equality except 
for stroke in men (p= 0,212) and in women (p=0,074).   
 
 
 
 
 
 
 
 
 59 
 
Table 5: Framingham 10-year risk of CVD event. Data from Cohort of Norway, 1994-2003. 
Calculated 10-year risk % in 60 015 participants a (95% CI), adjusted for age. 
 Men  Women 
 N Mean 95 % CI P (equality of 
immigrants) 
 N Mean 95 % CI P (equality of 
immigrants) 
          
Norway 26 400 14,16 14,06-14,25 Reference  30 384 7,05 7,00-7,11 Reference 
Eastern Europe 54 13,81 11,71-15,91 0,743  152 5,99 5,17-6,81 0,012* 
Former 
Yugoslavia 
90 15,14 13,52-16,77 0,237  78 8,00 6,86-9,15 0,105 
North Africa 37 14,76 12,22-17,29 0,644  29 6,29 4,41-8,17 0,429 
Sub-Saharan 
Africa 
104 11,95 10,44-13,46 0,004**  70 6,26 5,05-7,47 0,201 
Middle East 366 14,72 13,91-15,53 0,175  256 6,09 5,46-6,73 0,003** 
Indian 
Subcontinent 
574 14,74 14,10-15,38 0,080  420 6,65 6,16-7,14 0,113 
East Asia 41 11,42 9,02-13,83 0,026*  58 5,62 4,29-6,95 0,035* 
North America 70 12,69 10,85-14,53 0,118  106 5,65 4,67-6,64 0,005** 
South America 71 14,65 12,82-16,48 0,597  84 5,89 4,78-6,99 0,039* 
South-East Asia 207 13,72 12,65-14,79 0,419  364 5,60 5,07-6,13 <0,001*** 
Total 28 014     32 001    
P (overall equality)   0,010**     <0,001*** 
     aParticipants free of CVD.  *P<0.05,  **P<0.01,   ***P<0.001 
 
Table 6: NORRISK 10-year risk of CVD death. Data from Cohort of Norway, 1994-2003. 
Calculated 10-year risk % in 54 027 participants a (95% CI), adjusted to age. 
 Men  Women 
 N Mea
n 
95 % CI P (equality of 
immigrants) 
 N Mean 95 % CI  
          
Norway 23 880 4,99 4,94-5,05 Reference  27 510 1,73 1,70-1,76  
Eastern Europe 51 5,26 4,08-6,43 0,660  132 1,65 1,25-2,05  
Former Yugoslavia 75 4,67 3,70-5,64 0,512  68 2,00 1,44-2,55  
North Africa 31 3,44 1,93-4,95 0,043*  21 1,91 0,91-2,91  
Sub-Saharan Africa 94 4,80 3,93-5,67 0,662  59 2,04 1,44-2,64  
Middle East 297 4,11 3,62-4,59 <0,001***  193 1,36 1,03-1,69  
Indian Subcontinent 438 4,67 4,27-5,07 0,119  304 1,67 1,41-1,94  
East Asia 34 3,60 2,16-5,04 0,059  50 1,62 0,97-2,27  
North America 63 5,52 4,46-6,58 0,333  98 1,71 1,25-2,18  
South America 66 4,23 3,19-5,26 0,148  78 1,74 1,22-2,26  
South-East Asia 175 3,91 3,27-4,55 0,001***  310 1,70 1,44-1,96  
Total 25 204     28 823    
P (overall equality)     <0,001***     0,676 
 
aParticipants free of CVD, diabetes and who have never used antihypertensive- and/or lipid-lowering treatment. Post hoc test was 
not performed for women since overall variance was not statistically significant.  *P<0.05,  **P<0.01,  ***P<0.001.    
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Figure 1: Prevalence (%) of risk factors in 62 145 participants, adjusted to age. TC, total cholesterol; HDL, high density 
lipoprotein; WHR, waist hip ratio; BMI, body mass index. All prevalence variables had P-values < 0,001 for overall equality except for 
hypertension in women (p=0,031). Data from Cohort of Norway, 1994-2003. 
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Figure 2a: Prevalence (%) of people defined as in high risk of developing CVD within 10 years in 60 015 participants 
according to the Framingham equation. Estimates are adjusted to age. Overall variance was significant in both men 
(p=0,001) and women (p=0,002). Data from Cohort of Norway, 1994-2003. 
 
  
Figure 2b: Prevalence (%) of people defined as in high risk of dying from CVD within 10 years in 54 027 participants 
according to the NORRISK equation. Estimates are adjusted to age. Overall variance was significant in men (p=0,033) 
but not in women (p=0,103). Data from Cohort of Norway, 1994-2003. 
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Appendix:  
Extract from the CONOR-questionnaire:  
 
2. Do you have, or have you had? 
                                                                Yes     No    Age first time 
Heart attack 
Angina pectoris (heart cramp) 
Cerebral stroke/Brain haemorrhage 
Asthma 
Diabetes 
  
5a. How has your physical activity during leisure time been over the last year?  
Think of your weekly average for the year. Time spent going to  or from work counts as leisure time  
Hours per week                      
                                                           None     Less than 1     1-2     3 or more 
Light activity 
 (not sweating or out of breath) 
  
Hard physical activity 
(sweating/out of breath) 
 
9. Do you smoke? 
                                                               Yes            No 
Cigarettes daily 
Cigars/cigarillos daily 
Pipe daily 
 
18 b. How many years education have you completed all together? 
(Count every year you went to school) 
Number of years…………. 
 
 
45. Do you take?  
                                    Currently             Previously               Never 
Lipid lowering drugs 
  
Medications for high blood pressure 
 
The complete CONOR-questionnaire can be downloaded through this webpage: 
http://www.fhi.no/dokumenter/4fe7c0f0e2.xls 
 
